10-Q: Quarterly report pursuant to Section 13 or 15(d)
Published on August 8, 2019
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
(Mark One) |
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
For the quarterly period ended | |
OR | |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
For the transition period from to | |
Commission file number
(Exact name of registrant as specified in its charter)
|
|
|
|
Registrant’s telephone number, including area code: (
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulations S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Accelerated filer ☐ |
Non-accelerated filer ☐ |
Smaller reporting company
Emerging growth company |
If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standard provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading Symbol |
Name of each exchange on which registered |
||
Title of each class of common stock |
|
Number of shares |
Class A common stock |
|
|
AMC ENTERTAINMENT HOLDINGS, INC.
INDEX
Page |
||
3 |
||
Condensed Consolidated Statements of Operations |
3 |
|
Condensed Consolidated Statements of Comprehensive Income (Loss) |
4 |
|
Condensed Consolidated Balance Sheets |
5 |
|
Condensed Consolidated Statements of Cash Flows |
6 |
|
8 |
||
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
48 |
|
71 |
||
72 |
||
73 |
||
73 |
||
73 |
||
73 |
||
73 |
||
74 |
||
75 |
2
PART I—FINANCIAL INFORMATION
Item 1. Financial Statements. (Unaudited)
AMC ENTERTAINMENT HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Three Months Ended |
Six Months Ended |
|||||||||||
(in millions, except share and per share amounts) |
|
June 30, 2019 |
|
June 30, 2018 |
|
June 30, 2019 |
|
June 30, 2018 |
||||
(unaudited) |
(unaudited) |
|||||||||||
Revenues |
||||||||||||
Admissions |
$ |
|
$ |
|
$ |
|
$ |
|
||||
Food and beverage |
|
|
|
|
|
|
|
|
||||
Other theatre |
|
|
|
|
|
|
|
|
||||
Total revenues |
|
|
|
|
||||||||
Operating costs and expenses |
||||||||||||
Film exhibition costs |
|
|
|
|
|
|
||||||
Food and beverage costs |
|
|
|
|
|
|
|
|
||||
Operating expense, excluding depreciation and amortization below |
|
|
|
|
|
|
|
|
||||
Rent |
|
|
|
|
|
|
|
|
||||
General and administrative: |
||||||||||||
Merger, acquisition and transaction costs |
|
|
|
|
|
|
|
|
||||
Other, excluding depreciation and amortization below |
|
|
|
|
|
|
|
|
||||
Depreciation and amortization |
|
|
|
|
||||||||
Operating costs and expenses |
|
|
|
|
|
|
||||||
Operating income |
|
|
|
|
||||||||
Other expense (income): |
||||||||||||
Other expense (income) |
|
( |
|
|
|
|
|
|
||||
Interest expense: |
||||||||||||
Corporate borrowings |
|
|
|
|
|
|
|
|
||||
Capital and financing lease obligations |
|
|
|
|
|
|
|
|
||||
Non-cash NCM exhibitor services agreement |
|
|
|
|
||||||||
Equity in earnings of non-consolidated entities |
|
( |
|
( |
|
( |
|
( |
||||
Investment income |
|
( |
|
( |
|
( |
|
( |
||||
Total other expense |
|
|
|
|
|
|
||||||
Earnings (loss) before income taxes |
|
|
|
|
( |
|
||||||
Income tax provision (benefit) |
|
|
|
( |
|
|
|
|||||
Net earnings (loss) |
$ |
|
$ |
|
$ |
( |
$ |
|
||||
Earnings (loss) per share: |
||||||||||||
Basic |
$ |
|
$ |
|
$ |
( |
$ |
|
||||
Diluted |
$ |
|
$ |
|
$ |
( |
$ |
|
||||
Average shares outstanding: |
||||||||||||
Basic (in thousands) |
|
|
|
|
||||||||
Diluted (in thousands) |
|
|
|
|
||||||||
See Notes to Condensed Consolidated Financial Statements.
3
AMC ENTERTAINMENT HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
Three Months Ended |
Six Months Ended |
|||||||||||
(in millions) |
|
June 30, 2019 |
|
June 30, 2018 |
|
June 30, 2019 |
|
June 30, 2018 |
||||
Net earnings (loss) |
$ |
|
$ |
|
$ |
( |
$ |
|
||||
Other comprehensive income (loss) |
||||||||||||
Unrealized foreign currency translation adjustment |
|
( |
|
( |
|
( |
|
( |
||||
Realized loss on foreign currency transactions reclassified into other expense, net of tax |
|
|
|
|
||||||||
Pension and other benefit adjustments: |
||||||||||||
Net gain (loss) arising during the period, net of tax |
|
|
|
( |
|
|
|
( |
||||
Equity method investees' cash flow hedge: |
||||||||||||
Unrealized net holding gain (loss) arising during the period, net of tax |
|
( |
|
— |
|
( |
|
|
||||
Realized net gain reclassified into equity in earnings of non-consolidated entities, net of tax |
— |
( |
— |
( |
||||||||
Other comprehensive loss |
|
( |
|
( |
|
( |
|
( |
||||
Total comprehensive income (loss) |
$ |
|
$ |
( |
$ |
( |
$ |
( |
||||
See Notes to Condensed Consolidated Financial Statements.
4
AMC ENTERTAINMENT HOLDINGS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(In millions, except share data) |
|
June 30, 2019 |
|
December 31, 2018 |
|
||
ASSETS |
|||||||
Current assets: |
|||||||
Cash and cash equivalents |
$ |
|
$ |
|
|||
Restricted cash |
|
|
|||||
Receivables, net |
|
|
|
|
|||
Other current assets |
|
|
|
|
|||
Total current assets |
|
|
|
|
|||
Property, net |
|
|
|
|
|||
Operating right-of-use assets, net |
|
— |
|||||
Intangible assets, net |
|
|
|
|
|||
Goodwill |
|
|
|
|
|||
Deferred tax asset, net |
|
|
|
|
|||
Other long-term assets |
|
|
|
|
|||
Total assets |
$ |
|
$ |
|
|||
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|||||||
Current liabilities: |
|||||||
Accounts payable |
$ |
|
$ |
|
|||
Accrued expenses and other liabilities |
|
|
|
|
|||
Deferred revenues and income |
|
|
|
|
|||
Current maturities of corporate borrowings |
|
|
|
|
|||
Current maturities of finance lease liabilities |
|
— |
|||||
Current maturities of operating lease liabilities |
|
— |
|||||
Current maturities of capital and financing lease obligations |
— |
|
|||||
Total current liabilities |
|
|
|
|
|||
Corporate borrowings |
|
|
|
|
|||
Finance lease liabilities |
|
|
|||||
Operating lease liabilities |
|
— |
|||||
Exhibitor services agreement |
|
|
|
|
|||
Deferred tax liability, net |
|
|
|
|
|||
Other long-term liabilities |
|
|
|
|
|||
Total liabilities |
|
|
|
|
|||
Commitments and contingencies |
|||||||
Class A common stock (temporary equity) ($ |
|
— |
|
|
|||
Stockholders’ equity: |
|||||||
Class A common stock ($ |
|
|
|
|
|||
Class B common stock ($ |
|
|
|
|
|||
Additional paid-in capital |
|
|
|
|
|||
Treasury stock ( |
|
( |
|
( |
|||
Accumulated other comprehensive income (loss) |
|
( |
|
|
|||
Accumulated deficit |
|
( |
|
( |
|||
Total stockholders’ equity |
|
|
|
|
|||
Total liabilities and stockholders’ equity |
$ |
|
$ |
|
|||
See Notes to Condensed Consolidated Financial Statements.
5
AMC ENTERTAINMENT HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in millions)
Six Months Ended |
||||||
June 30, 2019 |
June 30, 2018 |
|||||
Cash flows from operating activities: |
(Unaudited) |
|||||
Net earnings (loss) |
$ |
( |
$ |
|
||
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities: |
||||||
Depreciation and amortization |
|
|
||||
Deferred income taxes |
|
( |
||||
Amortization of net discount (premium) on corporate borrowings |
|
( |
||||
Amortization of deferred charges to interest expense |
|
|
||||
Non-cash portion of stock-based compensation |
|
|
||||
Gain on dispositions |
( |
( |
||||
Gain on disposition of NCM |
— |
( |
||||
Gain on derivative asset and derivative liability |
( |
— |
||||
Loss on repayment of indebtedness |
|
— |
||||
Equity in (earnings) loss from non-consolidated entities, net of distributions |
( |
|
||||
NCM held-for-sale impairment loss |
— |
|
||||
Landlord contributions |
|
|
||||
Non-cash rent - purchase accounting |
|
— |
||||
Deferred rent |
( |
( |
||||
Net periodic benefit cost |
|
|
||||
Change in assets and liabilities, excluding acquisitions: |
||||||
Receivables |
|
|
||||
Other assets |
|
( |
||||
Accounts payable |
( |
( |
||||
Accrued expenses and other liabilities |
( |
( |
||||
Other, net |
( |
( |
||||
Net cash provided by operating activities |
|
|
||||
Cash flows from investing activities: |
||||||
Capital expenditures |
( |
( |
||||
Proceeds from sale leaseback transactions |
— |
|
||||
Proceeds from disposition of NCM |
— |
|
||||
Acquisition of theatre assets |
( |
— |
||||
Proceeds from disposition of long-term assets |
|
|
||||
Investments in non-consolidated entities, net |
( |
( |
||||
Other, net |
( |
( |
||||
Net cash used in investing activities |
( |
( |
||||
Cash flows from financing activities: |
||||||
Proceeds from issuance of Term Loan due 2026 |
|
— |
||||
Payment of principal Senior Secured Notes due 2023 |
( |
— |
||||
Payment of principal Senior Subordinated Notes due 2022 |
( |
— |
||||
Call premiums paid for Senior Secured Notes due 2023 and Senior Subordinated Notes due 2022 |
( |
— |
||||
Principal payment of Term Loans due 2022 and 2023 |
( |
— |
||||
Repayments under revolving credit facilities |
( |
— |
||||
Scheduled principal payments under Term Loans |
( |
( |
||||
Principal payments under capital and financing lease obligations |
( |
( |
||||
Cash used to pay for debt financing costs |
( |
( |
||||
Cash used to pay dividends |
( |
( |
||||
Taxes paid for restricted unit withholdings |
( |
( |
||||
Purchase of treasury stock |
— |
( |
||||
Net cash used in financing activities |
( |
( |
||||
6
Effect of exchange rate changes on cash and cash equivalents and restricted cash |
( |
|
||||
Net increase (decrease) in cash and cash equivalents and restricted cash |
( |
|
||||
Cash and cash equivalents and restricted cash at beginning of period |
|
|
||||
Cash and cash equivalents and restricted cash at end of period |
$ |
|
$ |
|
||
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: |
||||||
Cash paid during the period for: |
||||||
Interest (including amounts capitalized of $ |
$ |
|
$ |
|
||
Income taxes paid (received), net |
$ |
( |
$ |
|
||
Schedule of non-cash activities: |
||||||
Investment in NCM (See Note 5—Investments) |
$ |
|
$ |
( |
||
Construction payables at period end |
$ |
|
$ |
|
||
Accrued treasury stock payable at period end |
$ |
— |
$ |
|
See Notes to Condensed Consolidated Financial Statements.
7
AMC ENTERTAINMENT HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2019
(Unaudited)
NOTE 1—BASIS OF PRESENTATION
AMC Entertainment Holdings, Inc. (“Holdings”), through its direct and indirect subsidiaries, including American Multi-Cinema, Inc. and its subsidiaries, (collectively with Holdings, unless the context otherwise requires, the “Company” or “AMC”), is principally involved in the theatrical exhibition business and owns, operates or has interests in theatres located in the United States and Europe. Holdings is an indirect subsidiary of Dalian Wanda Group Co., Ltd. (“Wanda”), a Chinese private conglomerate.
As of June 30, 2019, Wanda owned approximately
Use of Estimates: The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Principles of Consolidation: The accompanying unaudited condensed consolidated financial statements include the accounts of Holdings and all subsidiaries, as discussed above, and should be read in conjunction with the Company’s Annual Report on Form 10–K for the year ended December 31, 2018. The accompanying condensed consolidated balance sheet as of December 31, 2018, which was derived from audited financial statements, and the unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and in accordance with the instructions to Form 10–Q. Accordingly, they do not include all of the information and footnotes required by the accounting principles generally accepted in the United States of America for complete consolidated financial statements. In the opinion of management, these interim financial statements reflect all adjustments (consisting of normal recurring adjustments) necessary for a fair statement of the Company’s financial position and results of operations. All significant intercompany balances and transactions have been eliminated in consolidation. There are
Accumulated depreciation and amortization: Accumulated depreciation was $
8
Other expense (income): The following table sets forth the components of other expense (income):
Three Months Ended |
Six Months Ended |
|||||||||||
(In thousands) |
June 30, 2019 |
June 30, 2018 |
June 30, 2019 |
June 30, 2018 |
||||||||
Derivative liability fair value adjustment for embedded conversion feature in the Convertible Notes due 2024 |
$ |
( |
$ |
— |
$ |
( |
$ |
— |
||||
Derivative asset fair value adjustment for contingent call option related to the Class B common stock purchase and cancellation agreement |
( |
— |
|
— |
||||||||
Loss on Pound sterling forward contract |
|
|
|
|
||||||||
Foreign currency transactions losses |
|
|
|
|
||||||||
Non-operating components of net periodic benefit cost |
|
|
|
|
||||||||
Loss on repayment of indebtedness |
|
— |
|
— |
||||||||
Other |
( |
|
|
|
||||||||
Total other expense (income) |
$ |
( |
$ |
|
$ |
|
$ |
|
||||
Accounting Pronouncements Recently Adopted
Leases.The Company adopted the guidance of ASU No. 2016-02, Leases (“ASC 842”) as of January 1, 2019 using the modified retrospective transition approach with the cumulative effect recognized at the date of initial application. The comparative information in the prior year has not been adjusted and continues to be reported under ASC 840, Leases, which was the accounting standard in effect for that period. ASC 842 requires lessees to recognize leases on-balance sheet and disclose key information about leasing arrangements. The new standard establishes a right-of-use model (“ROU”) that requires a lessee to recognize a ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement. See Note 2—Leases for the required disclosures of the nature, amount, timing, and uncertainty of cash flows arising from leases.
Accounting Pronouncements Issued Not Yet Adopted
Financial Instruments. In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), which provides new guidance regarding the measurement and recognition of credit impairment for certain financial assets. Such guidance will impact how the Company determines its allowance for estimated uncollectible receivables and evaluates its available-for-sale investments for impairment. ASU 2016-13 is effective for the Company in the first quarter of 2020. The Company is currently evaluating the effect that ASU 2016-13 will have on its consolidated financial statements and related disclosures.
Fair Value Measurement. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework–Changes to the Disclosure Requirements for Fair Value Measurement (“ASU 2018-13”), which eliminates, adds, and modifies certain disclosure requirements for fair value measurements as part of its disclosure framework project. Entities will no longer be required to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, but will be required to disclose the range and weighted average used to develop significant unobservable inputs for Level 3 fair value measurements. ASU 2018-13 is effective for the Company in the first quarter of 2020. Early adoption is permitted. The Company is currently evaluating the effect that ASU 2018-13 will have on its fair value measurement disclosures.
Cloud Computing Arrangement. In August 2018, the FASB issued ASU 2018-15, Intangibles–Goodwill and Other-Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (“ASU 2018-15”). ASU 2018-15 requires a customer in a cloud computing arrangement (i.e., hosting arrangement) that is a service contract to follow the internal-use software guidance in ASC 350-40 to determine which implementation, setup, and other upfront costs to capitalize as assets or expense as incurred. ASU 2018-15 is effective for the Company in the first quarter of 2020. Early adoption is permitted. Entities have the option to apply the guidance prospectively to all implementation costs incurred after the date of adoption or
9
retrospectively in accordance with ASC 250-10-45. The Company is currently evaluating the effect that ASU 2018-15 will have on its consolidated financial statements.
NOTE 2—LEASES
The Company adopted ASC 842 on January 1, 2019 using the modified retrospective transition method; and therefore, the comparative information has not been adjusted for the three months and six months ended June 30, 2018 or as of December 31, 2018. Upon transition to the new standard, the Company elected the package of practical expedients, which permitted the Company not to reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct costs.
The Company leases theatres and equipment under operating and finance leases. The majority of the Company’s operations are conducted in premises occupied under lease agreements with initial base terms ranging generally from
Operating lease right-of-use assets and lease liabilities were recognized at commencement date based on the present value of minimum lease payments over the remaining lease term. The minimum lease payments include base rent and other fixed payments, including fixed maintenance costs. The Company’s leases have remaining lease terms of approximately
The Company elected the practical expedient to not separate lease and non-lease components and also elected the short-term practical expedient for all leases that qualify. As a result, the Company will not recognize right-of-use assets or liabilities for short-term leases that qualify for the short-term practical expedient, but instead will recognize the lease payments as lease cost on a straight-line basis over the lease term. The Company’s lease agreements do not contain residual value guarantees. Short-term leases and sublease arrangements are immaterial. Equipment leases primarily consist of digital projectors and food and beverage equipment.
As a result of adopting ASC 842, the Company’s condensed consolidated balance sheet includes additional operating ROU assets and total operating lease liabilities of $
10
The following table provides the operating and finance ROU assets and lease liabilities:
(In millions) |
Balance Sheet Classification |
June 30, 2019 |
|||
Assets |
|||||
Operating lease right-of-use assets (1) |
Operating lease right-of-use assets |
$ |
|
||
Finance lease right-of-use assets (2) |
Property, net |
|
|||
Total leased assets |
$ |
|
|||
Liabilities |
|||||
Current |
|||||
Operating lease liabilities (1) |
Current maturities of operating lease liabilities |
$ |
|
||
Finance lease liabilities (2) |
Current maturities of finance lease liabilities |
|
|||
Noncurrent |
|||||
Operating lease liabilities (1) |
Operating lease liabilities |
|
|||
Finance lease liabilities (2) |
Finance lease liabilities |
|
|||
Total lease liabilities |
$ |
|
|||
The cumulative effect adjustment to accumulated deficit at January 1, 2019 is as follows:
Accumulated |
|||
(In millions) |
Deficit |
||
Balance as of December 31, 2018 |
$ |
( |
|
Derecognition of existing assets for certain sale leaseback transactions previously recorded in property, net |
( |
||
Derecognition of existing liabilities for certain sale leaseback transactions previously recorded in current maturities of corporate borrowings and capital and financing lease obligations |
|
||
Derecognition of deferred gains from the sale and leaseback transactions previously recorded in other long-term liabilities |
|
||
Difference in fair value compared to the basis of the right-of-use assets for previously impaired asset groups |
( |
||
Deferred taxes |
|
||
Cumulative effect adjustment to accumulated deficit |
|
||
Balance as of January 1, 2019 |
$ |
( |
|
11
The following is the impact of the adoption of ASC 842 on the Company’s condensed consolidated statement of operations for the three months ended June 30, 2019:
Three Months Ended June 30, 2019 |
||||||||||||
Without Adoption of |
U.S. Markets |
International Markets |
||||||||||
(In millions) |
ASC 842 |
Adjustments |
Adjustments |
As Reported |
||||||||
Operating costs and expenses |
||||||||||||
Rent (1)(2)(4) |
$ |
|
$ |
|
$ |
|
$ |
|
||||
Depreciation and amortization (2)(3) |
|
( |
( |
|
||||||||
Operating costs and expenses |
|
|
|
|
||||||||
Operating income |
|
( |
( |
|
||||||||
Other expense (income) |
||||||||||||
Interest expense: |
||||||||||||
Capital and financing lease obligations (1) |
|
( |
( |
|
||||||||
Net earnings |
|
( |
|
|
||||||||
The following is the impact of the adoption of ASC 842 on the Company’s condensed consolidated statement of operations for the six months ended June 30, 2019:
Six Months Ended June 30, 2019 |
||||||||||||
Without Adoption of |
U.S. Markets |
International Markets |
||||||||||
(In millions) |
ASC 842 |
Adjustments |
Adjustments |
As Reported |
||||||||
Operating costs and expenses |
||||||||||||
Rent (1)(2)(4) |
$ |
|
$ |
|
$ |
|
$ |
|
||||
Depreciation and amortization (2)(3) |
|
( |
( |
|
||||||||
Operating costs and expenses |
|
|
|
|
||||||||
Operating income |
|
( |
( |
|
||||||||
Other expense (income) |
||||||||||||
Interest expense: |
||||||||||||
Capital and financing lease obligations (1) |
|
( |
( |
|
||||||||
Net loss |
( |
( |
|
( |
||||||||
| (1) |
Cash rent payments for build-to-suit failed sale leasebacks of $ |
| (2) |
Non-cash amortization expense for favorable lease terms of $ |
| (3) | Depreciation on build-to-suit failed sale leaseback buildings that are eliminated upon adoption of ASC 842. |
12
| (4) |
Amortization of deferred gains on sale leaseback transactions of $ |
The following table reflects the lease costs for the three and six months ended June 30, 2019:
Condensed Consolidated |
Three Months Ended |
Six Months Ended |
||||||
(In millions) |
Statement of Operations |
June 30, 2019 |
June 30, 2019 |
|||||
Operating lease cost |
||||||||
Theatre properties |
Rent |
$ |
|
$ |
|
|||
Theatre properties |
Operating expense |
|
|
|||||
Equipment |
Operating expense |
|
|
|||||
Office and other |
General and administrative: other |
|
|
|||||
Finance lease cost |
||||||||
Amortization of finance lease assets |
Depreciation and amortization |
|
|
|||||
Interest on lease liabilities |
Finance lease liabilities |
|
|
|||||
Variable lease cost |
||||||||
Theatre properties |
Rent |
|
|
|||||
Equipment |
Operating expense |
|
|
|||||
Total lease cost |
$ |
|
$ |
|
||||
The following table represents the weighted-average remaining lease term and discount rate as of June 30, 2019:
As of June 30, 2019 |
||||||
Weighted Average |
Weighted Average |
|||||
Remaining |
Discount |
|||||
Lease Term and Discount Rate |
Lease Term (years) |
Rate |
||||
Operating leases |
||||||
Finance leases |
||||||
Cash flow and supplemental information is presented below:
Six Months Ended |
|||
(In millions) |
June 30, 2019 |
||
Cash paid for amounts included in the measurement of lease liabilities: |
|||
Operating cash flows used in finance leases |
$ |
( |
|
Operating cash flows used in operating lease cost |
( |
||
Financing cash flows used in finance leases |
( |
||
Landlord contributions: |
|||
Operating cashflows provided by operating leases |
|
||
Supplemental disclosure of noncash leasing activities: |
|||
Right-of-use assets obtained in exchange for new operating lease liabilities (1) |
|
||
| (1) | Includes lease extensions and an option exercise. |
13
Minimum annual payments required under existing operating and finance lease liabilities, (net present value thereof) as of June 30, 2019 are as follows:
Operating Lease |
Financing Lease |
|||||
(In millions) |
Payments (1)(2) |
Payments |
||||
Six months ended December 31, 2019 |
$ |
|
$ |
|
||
2020 |
|
|
||||
2021 |
|
|
||||
2022 |
|
|
||||
2023 |
|
|
||||
2024 |
|
|
||||
Thereafter |
|
|
||||
Total lease payments |
|
|
||||
Less imputed interest |
( |
( |
||||
Total |
$ |
|
$ |
|
||
As of June 30, 2019, the Company had signed additional operating lease agreements for
Minimum annual payments required under operating lease liabilities and capital and failed sale-leaseback, finance lease obligations, (net present value thereof) that have initial or remaining non-cancelable terms in excess of one year as of December 31, 2018 were as follows:
Capital and Finance Lease Obligations |
||||||||||||
Minimum Operating |
Minimum Lease |
|||||||||||
(In millions) |
Lease Payments |
Payments |
Less Interest |
Principal |
||||||||
2019 |
$ |
|
$ |
$ |
$ |
|||||||
2020 |
|
|||||||||||
2021 |
|
|||||||||||
2022 |
|
|||||||||||
2023 |
|
|||||||||||
Thereafter |
|
|||||||||||
Total minimum payments required |
$ |
|
$ |
|
$ |
|
$ |
|
||||
During the six months ended June 30, 2018, the Company modified the terms of an existing operating lease to reduce the lease term. The Company received a $
14
NOTE 3—REVENUE RECOGNITION
Disaggregation of Revenue: Revenue is disaggregated in the following tables by major revenue types and by timing of revenue recognition:
Three Months Ended |
Three Months Ended |
|||||
(In millions) |
June 30, 2019 |
June 30, 2018 |
||||
Major revenue types |
||||||
Admissions |
$ |
|
$ |
|
||
Food and beverage |
|
|
||||
Other theatre: |
||||||
Advertising |
|
|
||||
Other theatre |
|
|
||||
Other theatre |
|
|
||||
Total revenues |
$ |
|
$ |
|
||
Three Months Ended |
Three Months Ended |
|||||
(In millions) |
June 30, 2019 |
June 30, 2018 |
||||
Timing of revenue recognition |
||||||
Products and services transferred at a point in time |
$ |
|
$ |
|
||
Products and services transferred over time (1) |
|
|
||||
Total revenues |
$ |
|
$ |
|
||
Six Months Ended |
Six Months Ended |
|||||
(In millions) |
June 30, 2019 |
June 30, 2018 |
||||
Major revenue types |
||||||
Admissions |
$ |
|
$ |
|
||
Food and beverage |
|
|
||||
Other theatre: |
||||||
Advertising |
|
|
||||
Other theatre |
|
|
||||
Other theatre |
|
|
||||
Total revenues |
$ |
|
$ |
|
||
Six Months Ended |
Six Months Ended |
|||||
(In millions) |
June 30, 2019 |
June 30, 2018 |
||||
Timing of revenue recognition |
||||||
Products and services transferred at a point in time |
$ |
|
$ |
|
||
Products and services transferred over time (1) |
|
|
||||
Total revenues |
$ |
|
$ |
|
||
| (1) | Amounts primarily include subscription and advertising revenues. |
The following tables provide the balances of receivables and deferred revenue income:
(In millions) |
June 30, 2019 |
December 31, 2018 |
||||
Current assets: |
||||||
Receivables related to contracts with customers |
$ |
|
$ |
|
||
Miscellaneous receivables |
|
|
||||
Receivables, net |
$ |
|
$ |
|
||
15
(In millions) |
June 30, 2019 |
December 31, 2018 |
||||
Current liabilities: |
||||||
Deferred revenue related to contracts with customers |
$ |
|
$ |
|
||
Miscellaneous deferred income |
|
|
||||
Deferred revenue and income |
$ |
|
$ |
|
||
The significant changes in contract liabilities with customers included in deferred revenues and income are as follows:
Deferred Revenues |
|||
Related to Contracts |
|||
(In millions) |
with Customers |
||
Balance as of December 31, 2018 |
$ |
|
|
Cash received in advance (1) |
|
||
Customer loyalty rewards accumulated, net of expirations: |
|||
Admission revenues (2) |
|
||
Food and beverage (2) |
|
||
Other theatre (2) |
|
||
Reclassification to revenue as the result of performance obligations satisfied: |
|||
Admission revenues (3) |
( |
||
Food and beverage (3) |
( |
||
Other theatre (4) |
( |
||
Disposition of Austria theatres |
( |
||
Foreign currency translation adjustment |
( |
||
Balance as of June 30, 2019 |
$ |
|
|
The significant changes to contract liabilities included in the exhibitor services agreement, classified as long-term liabilities in the condensed consolidated balance sheets, are as follows:
Exhibitor Services |
|||
(In millions) |
Agreement |
||
Balance as of December 31, 2018 |
$ |
|
|
Common Unit Adjustment–additions of common units (1) |
|
||
Reclassification of the beginning balance to other theatre revenue, as the result of performance obligations satisfied |
( |
||
Balance as of June 30, 2019 |
$ |
|
|
16
Transaction Price Allocated to the Remaining Performance Obligations: The following table includes the amount of NCM ESA, included in deferred revenues and income in the Company’s condensed consolidated balance sheets, that is expected to be recognized as revenues in the future related to performance obligations that are unsatisfied as of June 30, 2019:
(In millions) |
Exhibitor services agreement |
||
Six Months Ended December 31, 2019 |
$ |
|
|
Year Ended 2020 |
|
||
Year Ended 2021 |
|
||
Year Ended 2022 |
|
||
Year Ended 2023 |
|
||
Year Ended 2024 |
|
||
Years Ended 2025 through February 2037 |
|
||
Total |
$ |
|
|
The total amount of non-redeemed gifts cards and exchange tickets included in deferred revenues and income as of June 30, 2019 was $
As of June 30, 2019, the amount of deferred revenue allocated to the AMC Stubs® loyalty programs included in deferred revenues and income was $
The Company applies the practical expedient in ASC 606-10-50-14 and does not disclose information about remaining performance obligations that have original expected durations of one year or less.
NOTE 4—GOODWILL
The following table summarizes the changes in goodwill by reportable segment for the six months ended June 30, 2019:
(In millions) |
|
U.S. Markets |
|
International Markets |
Total |
||||
Balance as of December 31, 2018 |
$ |
|
$ |
|
$ |
|
|||
Currency translation adjustment |
— |
( |
( |
||||||
Balance as of June 30, 2019 |
$ |
|
$ |
|
$ |
|
|||
The Company evaluates goodwill for impairment annually as of the beginning of the fourth fiscal quarter and any time an event occurs or circumstances change that would more likely than not reduce the fair value for a reporting unit below its carrying amount. A decline in our common stock price and the resulting impact on market capitalization is one of several factors we consider when making this evaluation. The Company’s market capitalization has been below carrying value since May 24, 2019. The recent declines in the trading price of the Company’s Class A common stock were not considered to be sustained declines and therefore were not an event that would require the Company to evaluate goodwill for impairment as of June 30, 2019.
17
NOTE 5—INVESTMENTS
Investments in non-consolidated affiliates and certain other investments accounted for under the equity method generally include all entities in which the Company or its subsidiaries have significant influence, but not more than
NCM Transaction. In March 2019, the NCM CUA resulted in a positive adjustment of
Equity in Earnings (Loss) of Non-Consolidated Entities
Aggregated condensed financial information of the Company’s significant non-consolidated equity method investment (DCIP) is shown below:
|
Three Months Ended |
Six Months Ended |
||||||||||
(In millions) |
|
June 30, 2019 |
|
June 30, 2018 |
|
June 30, 2019 |
|
June 30, 2018 |
||||
Revenues |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
Operating costs and expenses |
|
|
|
|
||||||||
Net earnings |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
The components of the Company’s recorded equity in earnings of non-consolidated entities are as follows:
Three Months Ended |
Six Months Ended |
|||||||||||
(In millions) |
|
June 30, 2019 |
|
June 30, 2018 |
|
June 30, 2019 |
|
June 30, 2018 |
||||
NCM and NCM, Inc. |
$ |
— |
$ |
|
$ |
— |
$ |
( |
||||
DCIP |
|
|
|
|
|
|
|
|
||||
Other |
|
|
|
|
|
|
|
|
||||
The Company’s recorded equity in earnings |
$ |
|
$ |
|
$ |
|
$ |
|
||||
Digital Cinema Media. The Company acquired its equity investment in DCM on November 30, 2016 in connection with the acquisition of Odeon. The Company receives advertising services from DCM for its Odeon theatres in International markets through a joint venture in which it has a
The Company recorded the following related party transactions with DCM:
As of |
|
As of |
||||
(In millions) |
|
June 30, 2019 |
|
December 31, 2018 |
||
Due from DCM for on-screen advertising revenue |
$ |
|
$ |
|
||
Loan receivable from DCM |
|
|
||||
Three Months Ended |
|
Six Months Ended |
||||||||||
(In millions) |
|
June 30, 2019 |
|
June 30, 2018 |
|
June 30, 2019 |
|
June 30, 2018 |
||||
DCM screen advertising revenues |
$ |
|
$ |
|
$ |
|
$ |
|
||||
DCIP Transactions. The Company pays equipment rent monthly and records the equipment rental expense on a straight-line basis over
18
The Company recorded the following related party transactions with DCIP:
As of |
|
As of |
|||||
(In millions) |
|
June 30, 2019 |
|
December 31, 2018 |
|
||
Due from DCIP for warranty expenditures |
$ |
|
$ |
|
|||
Deferred rent liability for digital projectors |
|
— |
|
|
|||
Three Months Ended |
Six Months Ended |
|||||||||||
(In millions) |
|
June 30, 2019 |
|
June 30, 2018 |
|
June 30, 2019 |
|
June 30, 2018 |
||||
Digital equipment rental expense |
$ |
|
$ |
|
$ |
|
$ |
|
||||
AC JV Transactions. The Company recorded the following related party transactions with AC JV:
As of |
|
As of |
|||||
(In millions) |
June 30, 2019 |
December 31, 2018 |
|
||||
Due to AC JV for Fathom Events programming |
|
|
|||||
Three Months Ended |
Six Months Ended |
|||||||||||
(In millions) |
|
June 30, 2019 |
|
June 30, 2018 |
|
June 30, 2019 |
|
June 30, 2018 |
||||
Film exhibition costs: |
||||||||||||
Gross exhibition cost on Fathom Events programming |
$ |
|
$ |
|
$ |
|
$ |
|
||||
Screenvision Transactions. The Company recorded the following related party transactions with Screenvision:
As of |
|
As of |
||||
(In millions) |
|
June 30, 2019 |
|
December 31, 2018 |
||
Due from Screenvision for on-screen advertising revenue |
$ |
|
$ |
|
||
Three Months Ended |
|
Six Months Ended |
||||||||||
(In millions) |
|
June 30, 2019 |
|
June 30, 2018 |
|
June 30, 2019 |
|
June 30, 2018 |
||||
Screenvision screen advertising revenues |
$ |
|
$ |
|
$ |
|
$ |
|
||||
Nordic JVs. The Company recorded the following related party transactions with the Nordic theatre JVs :
As of |
|
As of |
||||
(In millions) |
|
June 30, 2019 |
|
December 31, 2018 |
||
Due from Nordic JVs |
$ |
|
$ |
|
||
Due to Nordic JVs for management services |
|
|
||||
19
NOTE 6—CORPORATE BORROWINGS
A summary of the carrying value of corporate borrowings and capital and finance lease obligations is as follows:
(In millions) |
|
June 30, 2019 |
|
December 31, 2018 |
||
Odeon Revolving Credit Facility Due 2022 ( |
$ |
— |
$ |
|
||
Senior Secured Credit Facility-Term Loan due 2026 ( |
|
— |
||||
Senior Secured Credit Facility-Term Loan due 2022 |
— |
|
||||
Senior Secured Credit Facility-Term Loan due 2023 |
— |
|
||||
— |
|
|||||
|
|
|||||
|
|
|
|
|||
|
— |
|
|
|||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
Finance lease obligations |
|
|
|
|||
Debt issuance costs |
( |
( |
||||
Net discounts |
( |
( |
||||
Derivative liability |
|
|
||||
|
|
|
|
|||
Less: |
||||||
Current maturities corporate borrowings |
( |
|
( |
|||
Current maturities finance lease obligations |
( |
— |
||||
Current maturities capital and financing lease obligations |
— |
( |
||||
$ |
|
$ |
|
|||
Senior Secured Credit Facility – Term Loan due 2026
On April 22, 2019, the Company entered into the Sixth Amendment to Credit Agreement (the “Sixth Amendment”) amending the Credit Agreement dated April 30, 2013, by and among the Company, each lender party thereto and Citicorp North America, Inc. (“Citi”), as administrative agent. After giving effect to the Sixth Amendment, the Credit Agreement provides for senior secured financing of $
Facilities”). The loans were used to repay all of the Company’s existing term loans in an aggregate principal amount of approximately $
All obligations under the Credit Agreement are guaranteed by, subject to certain exceptions, each of the Company’s current and future wholly-owned material domestic restricted subsidiaries. All obligations under the Credit Agreement, and the guarantees of those obligations, are secured by substantially all of the assets of the Company and each guarantor, subject to customary exceptions, including:
| ● |
a pledge of |
20
| ● | a security interest in substantially all other tangible and intangible assets of the Company and each guarantor, subject to certain exceptions. |
The Credit Facilities will require the Company to prepay outstanding term loans, subject to certain exceptions, with:
| ● |
|
| ● |
|
| ● |
|
The foregoing mandatory prepayments will be used to reduce the installments of principal on the Term Loan Facility. The Company may voluntarily repay outstanding loans under the Credit Facilities at any time without premium or penalty, except (1) for customary “breakage” costs with respect to LIBOR loans under the Credit Facilities and (2) during the six months following the Amendment Closing Date, with respect to certain voluntary prepayments or refinancings of the Term Loan Facility that reduce the effective yield of the Term Loan Facility, which will be subject to a
Borrowings under the Term Loan Facility will bear interest at a rate per annum equal to, at the Company’s option, either (1) an applicable margin plus a base rate determined by reference to the highest of (a)
The Credit Agreement contains other customary terms, including (1) representations, warranties and affirmative covenants, (2) negative covenants, including limitations on indebtedness, liens, mergers and acquisitions, asset sales, investments, distributions, prepayments of subordinated debt and transactions with affiliates, in each case subject to baskets, thresholds and other exceptions, and (3) customary events of default.
The availability of certain baskets and the ability to enter into certain transactions will also be subject to compliance with certain financial ratios. In addition, the Revolving Credit Facility includes a maintenance covenant that requires, in certain circumstances, compliance with a certain secured leverage ratio.
Senior Unsecured Convertible Notes due 2024
Carrying value (in millions) as of June 30, 2019:
Carrying Value |
Carrying Value |
||||||||
as of |
Increase to |
as of |
|||||||
December 31, 2018 |
Net Earnings (Loss) |
June 30, 2019 |
|||||||
Principal balance |
$ |
$ |
— |
$ |
|
||||
Discount |
( |
|
( |
||||||
Debt issuance costs |
( |
|
( |
||||||
Derivative liability |
|
( |
|
||||||
Carrying Value |
$ |
|
$ |
( |
$ |
|
|||
21
On September 14, 2018, the Company issued $
The Company bifurcated the conversion feature from the principal balance of the Convertible Notes due 2024 as a derivative liability because (1) a conversion feature is not clearly and closely related to the debt instrument and the reset of the conversion price discussed in the following paragraph causes the conversion feature to not be considered indexed to the Company’s equity, (2) the conversion feature standing alone meets the definition of a derivative, and (3) the Convertible Notes due 2024 are not remeasured at fair value each reporting period with changes in fair value recorded in the condensed consolidated statement of operations. The initial derivative liability of $
The Convertible Notes due 2024 are generally not convertible to equity in the first year after issuance. Upon conversion by a holder thereof, the Company shall deliver, at its election, either cash, shares of the Company’s Class A common stock or a combination of cash and shares of the Company’s Class A common stock at a conversion rate of
22
are converted in connection with a Make-Whole Fundamental Change (as defined in the Indenture (the “Indenture”) governing the Convertible Notes due 2024) are, under certain circumstances, entitled to an increase in the conversion rate.
The Company has the option to redeem the Convertible Notes due 2024 for cash on or after the fifth anniversary of issuance at par if the price for the Company’s Class A common stock is equal to or greater than
With certain exceptions, upon a change of control of the Company or if the Company’s Class A common stock is not listed for trading on The New York Stock Exchange, The NASDAQ Global Select Market or The NASDAQ Global Market, the holders of the Convertible Notes due 2024 may require that the Company repurchase in cash all or part of the principal amount of the Convertible Notes due 2024 at a purchase price equal to the principal amount plus accrued and unpaid interest up to, but excluding, the date of repurchase. The Indenture includes restrictive covenants that, subject to specified exceptions and parameters, limit the ability of the Company to incur additional debt and limit the ability of the Company to incur liens with respect to the Company’s senior subordinated notes or any debt incurred to refinance the Company’s senior subordinated notes. The Indenture also includes customary events of default, which may result in the acceleration of the maturity of the Convertible Notes due 2024 under the Indenture.
The Convertible Notes due 2024 are general unsecured senior obligations of the Company and are fully and unconditionally guaranteed on a joint and several senior unsecured basis by all the Company’s existing and future domestic restricted subsidiaries that guarantee its other indebtedness.
On September 14, 2018, in connection with the issuance of the Convertible Notes due 2024, the Company entered into an investment agreement (the “Investment Agreement”) providing for, among other things, registration rights with respect to the Convertible Notes due 2024 and the shares of Class A common stock underlying the Convertible Notes due 2024. Subject to the terms of the Investment Agreement, the Company was required to file a registration statement with the SEC not later than three months from the issuance date of the Convertible Notes in order to provide for resales of the Convertible Notes due 2024 and the shares of Class A common stock underlying the Convertible Notes to be made on a delayed or continuous basis pursuant to Rule 415 under the Securities Act. The Company filed a registration statement with the SEC on December 14, 2018 to fulfill this requirement.
23
NOTE 7—STOCKHOLDERS’ EQUITY
Dividends
The following is a summary of dividends and dividend equivalents paid to stockholders during the three and six months ended June 30, 2019:
Amount per |
Total Amount |
|||||||||
|
|
|
Share of |
|
Declared |
|||||
Declaration Date |
Record Date |
Date Paid |
Common Stock |
(In millions) |
||||||
February 15, 2019 |
March 11, 2019 |
March 25, 2019 |
$ |
|
$ |
|
||||
May 3, 2019 |
June 10, 2019 |
June 24, 2019 |
|
|
||||||
On August 2, 2019, the Holdings’ Board of Directors declared a cash dividend in the amount of $
Related Party Transactions
As of June 30, 2019 and December 31, 2018, the Company recorded a receivable due from Wanda of $
On September 14, 2018, the Company entered into the Investment Agreement with Silver Lake Alpine, L.P., an affiliate of Silver Lake Group, L.L.C. (“Silver Lake”), relating to the issuance to Silver Lake (or its designated affiliates) of $
On September 14, 2018, the Company, Silver Lake and Wanda entered into a Right of First Refusal Agreement (the “ ROFR Agreement ”), which provides Silver Lake certain rights to purchase shares of the Company’s common stock that Wanda proposes to sell during a period of two years from the date of execution of the ROFR Agreement or, if earlier, until such time that Wanda and its affiliates cease to beneficially own at least
On September 14, 2018, the Company used the proceeds from the Convertible Notes due 2024, and pursuant to a stock repurchase agreement between the Company and Wanda, repurchased
Temporary Equity
24
Certain members of management had the right to require Holdings to repurchase the Class A common stock held by them under certain limited circumstances pursuant to the terms of a stockholders’ agreement. Beginning on January 1, 2016 (or upon the termination of a management stockholder’s employment by the Company without cause, by the management stockholder for good reason, or due to the management stockholder’s death or disability) management stockholders had the right, in limited circumstances, to require Holdings to purchase shares that were not fully and freely tradeable at a price equal to the price per share paid by such management stockholder with appropriate adjustments for any subsequent events such as dividends, splits, or combinations. The shares of Class A common stock, subject to the stockholder agreement, were classified as temporary equity, apart from permanent equity, as a result of the contingent redemption feature contained in the stockholder agreement. The Company determined the amount reflected in temporary equity for the Class A common stock-based on the price paid per share by the management stockholders and Wanda on August 30, 2012, the date Wanda acquired Holdings.
As of January 1, 2019, the temporary equity program expired and management employees who held
Stock-Based Compensation
Holdings adopted a stock-based compensation plan in December of 2013.
During the three and six months ended June 30, 2019, the Company recognized stock-based compensation expense of $
The components of the Company’s recorded and unrecognized stock-based compensation expense are as follows:
Additional |
||||||||||||||||||
Amount Recognized |
Amount Recognized |
Amount |
Expected to |
Expected to |
Expected to |
|||||||||||||
Three Months Ended |
Six Months Ended |
Unrecognized |
Recognize |
Recognize |
Recognize |
|||||||||||||
Grant Tranche |
June 30, 2019 |
June 30, 2019 |
June 30, 2019 |
2019 |
2020 |
2021 |
||||||||||||
2019 Board of Directors |
$ |
— |
$ |
|
$ |
— |
$ |
— |
$ |
— |
$ |
— |
||||||
2019 RSU awards |
|
|
|
|
|
|
||||||||||||
2019 PSU awards |
|
|
|
|
|
|
||||||||||||
2018 RSU awards |
|
|
|
|
|
— |
||||||||||||
2018 PSU awards |
|
|
|
|
|
— |
||||||||||||
2017 RSU awards |
|
|
|
|
— |
— |
||||||||||||
2017 RSU NEO awards |
|
|
|
|
— |
— |
||||||||||||
2017 PSU awards (1) |
— |
— |
— |
— |
— |
— |
||||||||||||
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
| (1) | During the year ended December 31, 2017, the Company determined that achieving the three-year performance thresholds of the 2017 Performance Stock Units was improbable and reversed all previously recorded expense and ceased accruing any additional expense on these units. If the Company later determines that the performance thresholds become probable, then historical expense would be reinstated, and the Company would resume recognizing expense. |
Awards Granted in 2019
The Company’s Board of Directors approved awards of stock, restricted stock units (“RSUs”), and performance stock units (“PSUs”) to certain of the Company’s employees and directors under the Plan. The fair value of the stock at the grant date of March 6, 2019 was $
The award agreements generally had the following features:
25
| ● |
Stock Award: On March 6, 2019, |
The Company recognized approximately $
| ● |
Restricted Stock Unit Awards: On March 6, 2019, RSU awards of |
| ● |
Performance Stock Unit Award: On March 6, 2019, PSU awards of |
The following table represents the nonvested RSU and PSU activity for the six months ended June 30, 2019:
|
|
Weighted |
|||
Average |
|||||
Shares of RSU |
Grant Date |
||||
and PSU |
Fair Value |
||||
Beginning balance at January 1, 2019 |
|
$ |
|
||
Granted |
|
|
|||
Vested |
( |
|
|||
Forfeited |
( |
|
|||
Cancelled (1) |
( |
|
|||
Nonvested at June 30, 2019 |
|
$ |
|
||
| (1) | Represents vested RSUs surrendered in lieu of taxes and returned to the 2013 Equity Incentive Plan. |
26
Condensed Consolidated Statements of Stockholders’ Equity
For the Six Months Ended June 30, 2019
Accumulated |
|||||||||||||||||||||||||||
Class A Voting |
Class B Voting |
Additional |
Other |
Accumulated |
Total |
||||||||||||||||||||||
Common Stock |
Common Stock |
Paid-in |
Treasury Stock |
Comprehensive |
Earnings |
Stockholders’ |
|||||||||||||||||||||
(In millions, except share and per share data) |
|
Shares |
|
Amount |
|
Shares |
|
Amount |
|
Capital |
Shares |
|
Amount |
|
Income (Loss) |
|
(Deficit) |
|
Equity |
||||||||
Balances December 31, 2018 |
|
$ |
|
|
$ |
|
$ |
|
|
$ |
( |
$ |
|
$ |
( |
$ |
|
||||||||||
Cumulative effect adjustments for the adoption of new accounting principles (ASU 842) |
— |
— |
— |
— |
— |
— |
— |
— |
|
|
|||||||||||||||||
Net loss |
— |
— |
— |
— |
— |
— |
— |
— |
( |
( |
|||||||||||||||||
Other comprehensive loss |
— |
— |
— |
— |
— |
— |
— |
( |
— |
( |
|||||||||||||||||
Dividends declared: |
|||||||||||||||||||||||||||
Class A common stock, $ |
— |
— |
— |
— |
— |
— |
— |
— |
( |
( |
|||||||||||||||||
Class B common stock, $ |
— |
— |
— |
— |
— |
— |
— |
— |
( |
( |
|||||||||||||||||
Taxes paid for restricted unit withholdings |
— |
— |
— |
— |
( |
— |
— |
— |
— |
( |
|||||||||||||||||
Reclassification from temporary equity |
|
— |
— |
— |
|
— |
— |
— |
— |
|
|||||||||||||||||
Stock-based compensation |
|
— |
— |
— |
|
— |
— |
— |
— |
|
|||||||||||||||||
Balances March 31, 2019 |
|
$ |
|
|
$ |
|
$ |
|
|
$ |
( |
$ |
( |
$ |
( |
$ |
|
||||||||||
Cumulative effect adjustments for the adoption of new accounting principles (ASU 842) |
— |
— |
— |
— |
— |
— |
— |
— |
( |
( |
|||||||||||||||||
Net earnings |
— |
— |
— |
— |
— |
— |
— |
— |
|
|
|||||||||||||||||
Other comprehensive loss |
— |
— |
— |
— |
— |
— |
— |
( |
— |
( |
|||||||||||||||||
Dividends declared: |
|||||||||||||||||||||||||||
Class A common stock, $ |
— |
— |
— |
— |
— |
— |
— |
— |
( |
( |
|||||||||||||||||
Class B common stock, $ |
— |
— |
— |
— |
— |
— |
— |
— |
( |
( |
|||||||||||||||||
Taxes paid for restricted unit withholdings |
— |
— |
— |
— |
( |
— |
— |
— |
— |
( |
|||||||||||||||||
Stock-based compensation |
|
— |
— |
— |
|
— |
— |
— |
— |
|
|||||||||||||||||
Balances June 30, 2019 |
|
$ |
|
|
$ |
|
$ |
|
|
$ |
( |
$ |
( |
$ |
( |
$ |
|
||||||||||
27
Condensed Consolidated Statements of Stockholders’ Equity
For the Six Months Ended June 30, 2018
Accumulated |
|||||||||||||||||||||||||||
Class A Voting |
Class B Voting |
Additional |
Other |
Accumulated |
Total |
||||||||||||||||||||||
Common Stock |
Common Stock |
Paid-in |
Treasury Stock |
Comprehensive |
Earnings |
Stockholders’ |
|||||||||||||||||||||
(In millions, except share and per share data) |
|
Shares |
|
Amount |
|
Shares |
|
Amount |
|
Capital |
Shares |
|
Amount |
|
Income (Loss) |
|
(Deficit) |
|
Equity |
||||||||
Balances December 31, 2017 |
|
$ |
|
|
$ |
|
$ |
|
|
$ |
( |
$ |
|
$ |
( |
$ |
|
||||||||||
Cumulative effect adjustments for the adoption of new accounting principles (ASU 606, ASU 2016-01 and ASU 2018-02) |
— |
— |
— |
— |
— |
— |
— |
|
( |
( |
|||||||||||||||||
Net earnings |
— |
— |
— |
— |
— |
— |
— |
— |
|
|
|||||||||||||||||
Other comprehensive income |
— |
— |
— |
— |
— |
— |
— |
|
— |
|
|||||||||||||||||
Dividends declared: |
|||||||||||||||||||||||||||
Class A common stock, $ |
— |
— |
— |
— |
— |
— |
— |
— |
( |
( |
|||||||||||||||||
Class B common stock, $ |
— |
— |
— |
— |
— |
— |
— |
— |
( |
( |
|||||||||||||||||
Reversed dividend accrual for nonvested PSU's |
— |
— |
— |
— |
— |
— |
— |
— |
|
|
|||||||||||||||||
RSUs surrendered to pay for payroll taxes |
— |
— |
— |
— |
( |
— |
— |
— |
— |
( |
|||||||||||||||||
Reclassification from temporary equity |
|
— |
— |
— |
|
— |
— |
— |
— |
|
|||||||||||||||||
Stock-based compensation |
|
— |
— |
— |
|
— |
— |
— |
— |
|
|||||||||||||||||
Balances March 31, 2018 |
|
$ |
|
|
$ |
|
$ |
|
|
$ |
( |
$ |
|
$ |
( |
$ |
|
||||||||||
Net earnings |
— |
— |
— |
— |
— |
— |
— |
— |
|
|
|||||||||||||||||
Other comprehensive loss |
— |
— |
— |
— |
— |
— |
— |
( |
— |
( |
|||||||||||||||||
Dividends declared: |
|||||||||||||||||||||||||||
Class A common stock, $ |
— |
— |
— |
— |
— |
— |
— |
— |
( |
( |
|||||||||||||||||
Class B common stock, $ |
— |
— |
— |
— |
— |
— |
— |
— |
( |
( |
|||||||||||||||||
Reclassification from temporary equity |
|
— |
— |
— |
|
— |
— |
— |
— |
|
|||||||||||||||||
Stock-based compensation |
— |
— |
— |
— |
|
— |
— |
— |
— |
|
|||||||||||||||||
Class A common stock repurchases |
— |
— |
— |
— |
— |
|
( |
— |
— |
( |
|||||||||||||||||
Balances June 30, 2018 |
|
$ |
|
|
$ |
|
$ |
|
|
$ |
( |
$ |
|
$ |
( |
$ |
|
||||||||||
28
NOTE 8—INCOME TAXES
The Company’s worldwide effective income tax rate is based on expected income, statutory rates, valuation allowances against deferred tax assets and tax planning opportunities available in the various jurisdictions in which it operates. For interim financial reporting, the Company estimates the worldwide annual income tax rate based on projected taxable income for the full year and records a quarterly income tax provision or benefit in accordance with the anticipated annual rate, adjusted for discrete items, if any. The Company refines the estimates of the year’s taxable income as new information becomes available, including actual year-to-date financial results. This continual estimation process often results in a change to the expected worldwide effective income tax rate for the year. When this occurs, the Company adjusts the income tax provision during the quarter in which the change in estimate occurs so that the year-to-date provision reflects the expected income tax rate. Significant judgment is required in determining the effective tax rate. The Company recognizes income tax-related interest expense and penalties as income tax expense and general and administrative expense, respectively.
At June 30, 2019 and December 31, 2018, the Company has net deferred tax liabilities of $
The projected worldwide effective tax rate based on annual projected earnings for the year ending December 31, 2019 is (
Tax contingencies and other income tax liabilities were $
While the Tax Reform Act provides for a territorial tax system, beginning in 2018, it includes the global intangible low-taxed income (“GILTI”) provisions. The GILTI provisions require the Company to include in its U.S. income tax return foreign subsidiary earnings in excess of an allowable return on the foreign subsidiary’s tangible assets. For 2019, the Company does not anticipate a GILTI inclusion.
29
NOTE 9—FAIR VALUE MEASUREMENTS
Fair value refers to the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the market in which the entity transacts business. The inputs used to develop these fair value measurements are established in a hierarchy, which ranks the quality and reliability of the information used to determine the fair values. The fair value classification is based on levels of inputs. Assets and liabilities that are carried at fair value are classified and disclosed in one of the following categories:
Level 1: |
Quoted market prices in active markets for identical assets or liabilities. |
Level 2: |
Observable market based inputs or unobservable inputs that are corroborated by market data. |
Level 3: |
Unobservable inputs that are not corroborated by market data. |
Recurring Fair Value Measurements. The following table summarizes the fair value hierarchy of the Company’s financial assets and liabilities carried at fair value on a recurring basis as of June 30, 2019:
Fair Value Measurements at June 30, 2019 Using |
||||||||||||
Significant |
||||||||||||
|
Total Carrying |
|
Quoted prices in |
|
Significant other |
|
unobservable |
|||||
Value at |
active market |
observable inputs |
inputs |
|||||||||
(In millions) |
June 30, 2019 |
(Level 1) |
(Level 2) |
(Level 3) |
||||||||
Other long-term assets: |
||||||||||||
Money market mutual funds |
$ |
|
$ |
|
$ |
— |
$ |
— |
||||
Derivative asset |
|
— |
— |
|
||||||||
Investments measured at net asset value (1) |
|
|
— |
|
— |
|
— |
|||||
Equity securities, available-for-sale: |
||||||||||||
Investment in NCM |
|
|
— |
— |
||||||||
Total assets at fair value |
$ |
|
$ |
|
$ |
— |
$ |
|
||||
Corporate Borrowings: |
||||||||||||
Derivative liability |
$ |
|
$ |
— |
$ |
— |
$ |
|
||||
Total liabilities at fair value |
$ |
|
$ |
— |
$ |
— |
$ |
|
||||
| (1) | The investments relate to non-qualified deferred compensation arrangements on behalf of certain members of management. The Company has an equivalent liability for this related-party transaction recorded in other long-term liabilities for the deferred compensation obligation. |
Valuation Techniques. The Company’s money market mutual funds are invested in funds that seek to preserve principal, are highly liquid, and therefore are recorded on the balance sheet at the principal amounts deposited, which equals fair value. See Note 10—Accumulated Other Comprehensive Income for the unrealized gain on the equity securities recorded in accumulated other comprehensive income.
On September 14, 2018, the Company issued Convertible Notes due 2024 with a conversion feature that gave rise to an embedded derivative instrument and a stock purchase and cancellation agreement that gave rise to a derivative asset (See Note 6—Corporate Borrowings). The derivative features have been valued using a Monte Carlo simulation approach. The Monte Carlo simulation approach consists of simulated common stock prices from the valuation date to the maturity of the Convertible Notes and to September 14, 2020 for the contingent call option for forfeiture shares. Increases or decreases in the Company’s share price, the volatility of the share price, the passage of time, risk-free interest rate, discount yield, and dividend yield will all impact the value of the derivative instruments. The Company re-values the derivative instruments at the end of each reporting period and any changes are recorded in other expense (income) in the condensed consolidated statements of operations.
30
Other Fair Value Measurement Disclosures. The Company is required to disclose the fair value of financial instruments that are not recognized at fair value in the statement of financial position for which it is practicable to estimate that value:
|
Fair Value Measurements at June 30, 2019 Using |
|||||||||||
|
|
Significant other |
|
Significant |
||||||||
Total Carrying |
Quoted prices in |
observable |
unobservable |
|||||||||
Value at |
active market |
inputs |
inputs |
|||||||||
(In millions) |
June 30, 2019 |
(Level 1) |
(Level 2) |
(Level 3) |
||||||||
Current maturities of corporate borrowings |
$ |
|
$ |
— |
$ |
|
$ |
|
||||
Corporate borrowings |
|
|
|
— |
|
|
|
|||||
Valuation Technique. Quoted market prices and observable market based inputs were used to estimate fair value for Level 2 inputs. The Level 3 fair value measurement represents the transaction price of the corporate borrowings under market conditions. On September 14, 2018, the Company issued $
The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable, and accrued liabilities approximate fair value because of the short maturity of these instruments.
NOTE 10—ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
The following table presents the change in accumulated other comprehensive income (loss) by component:
Unrealized Net |
Unrealized Net |
|
||||||||||||||
Pension and |
Gain from |
Gain from Equity |
|
|||||||||||||
Foreign |
Other |
Marketable |
Method Investees’ |
|
||||||||||||
(In millions) |
|
Currency |
|
Benefits (1) |
|
Securities |
|
Cash Flow Hedge |
|
Total |
|
|||||
Balance, December 31, 2018 |
$ |
|
$ |
( |
$ |
— |
$ |
|
$ |
|
||||||
Other comprehensive income (loss) before reclassifications |
|
( |
|
|
|
— |
|
( |
|
( |
||||||
Amounts reclassified from accumulated other comprehensive income |
|
|
|
— |
|
— |
|
— |
|
|
||||||
Balance, June 30, 2019 |
$ |
( |
$ |
( |
$ |
— |
$ |
— |
$ |
( |
||||||
The tax effects allocated to each component of other comprehensive income (loss) during the three months ended June 30, 2019 and June 30, 2018 are as follows:
Three Months Ended |
||||||||||||||||||
June 30, 2019 |
June 30, 2018 |
|||||||||||||||||
|
|
Tax |
|
|
|
Tax |
|
|||||||||||
Pre-Tax |
(Expense) |
Net-of-Tax |
Pre-Tax |
(Expense) |
Net-of-Tax |
|||||||||||||
(In millions) |
Amount |
Benefit |
Amount |
Amount |
Benefit |
Amount |
||||||||||||
Unrealized foreign currency translation adjustment (1) |
$ |
( |
$ |
— |
$ |
( |
$ |
( |
$ |
( |
$ |
( |
||||||
Realized loss on foreign currency transactions |
|
— |
|
|
— |
|
||||||||||||
Pension and other benefit adjustments: |
||||||||||||||||||
Net gain (loss) arising during the period |
|
|
|
— |
|
|
|
( |
|
|
|
( |
||||||
Equity method investees' cash flow hedge: |
||||||||||||||||||
Unrealized net holding loss arising during the period |
|
( |
|
— |
|
( |
|
— |
|
— |
|
— |
||||||
Realized net loss reclassified into equity in earnings of non-consolidated entities |
— |
— |
— |
( |
— |
( |
||||||||||||
Other comprehensive loss |
$ |
( |
$ |
— |
$ |
( |
$ |
( |
$ |
( |
$ |
( |
||||||
| (1) | Deferred tax impacts of foreign currency translation for the Odeon and Nordic international operations have not been recorded due to the Company’s intent to remain permanently invested. |
31
The tax effects allocated to each component of other comprehensive income (loss) during the six months ended June 30, 2019 and June 30, 2018 are as follows:
Six Months Ended |
||||||||||||||||||
June 30, 2019 |
June 30, 2018 |
|||||||||||||||||
|
|
Tax |
|
|
|
Tax |
|
|||||||||||
Pre-Tax |
(Expense) |
Net-of-Tax |
Pre-Tax |
(Expense) |
Net-of-Tax |
|||||||||||||
(In millions) |
Amount |
Benefit |
Amount |
Amount |
Benefit |
Amount |
||||||||||||
Unrealized foreign currency translation adjustment (1) |
$ |
( |
$ |
— |
$ |
( |
$ |
( |
$ |
|
$ |
( |
||||||
Realized loss on foreign currency transactions |
|
— |
|
|
— |
|
||||||||||||
Pension and other benefit adjustments: |
||||||||||||||||||
Net gain (loss) arising during the period |
|
— |
|
( |
|
( |
||||||||||||
Equity method investees' cash flow hedge: |
||||||||||||||||||
Unrealized net holding gain (loss) arising during the period |
|
( |
|
— |
|
( |
|
|
|
— |
|
|
||||||
Realized net (gain) loss reclassified into equity in earnings of non-consolidated entities |
— |
— |
— |
( |
— |
( |
||||||||||||
Other comprehensive loss |
$ |
( |
$ |
— |
$ |
( |
$ |
( |
$ |
|
$ |
( |
||||||
NOTE 11—OPERATING SEGMENTS
The Company reports information about operating segments in accordance with ASC 280-10, Segment Reporting, which requires financial information to be reported based on the way management organizes segments within a company for making operating decisions and evaluating performance. The Company has identified
Below is a breakdown of select financial information by reportable operating segment:
Three Months Ended |
Six Months Ended |
|||||||||||
Revenues (In millions) |
|
June 30, 2019 |
June 30, 2018 |
June 30, 2019 |
|
June 30, 2018 |
||||||
U.S. markets |
$ |
|
$ |
|
$ |
|
|
$ |
|
|||
International markets |
|
|
|
|
|
|||||||
Total revenues |
$ |
|
$ |
|
$ |
|
|
$ |
|
|||
Three Months Ended |
Six Months Ended |
|||||||||||
Adjusted EBITDA (1) (In millions) |
|
June 30, 2019 |
|
June 30, 2018 |
June 30, 2019 |
|
June 30, 2018 |
|||||
U.S. markets (2) |
$ |
|
$ |
|
$ |
|
$ |
|
||||
International markets |
|
|
|
|
||||||||
Total Adjusted EBITDA |
$ |
|
$ |
|
$ |
|
$ |
|
||||
| (1) | The Company presents Adjusted EBITDA as a supplemental measure of its performance. The Company defines Adjusted EBITDA as net earnings (loss) plus (i) income tax provision (benefit), (ii) interest expense and (iii) depreciation and amortization, as further adjusted to eliminate the impact of certain items that the Company |
32
| does not consider indicative of its ongoing operating performance and to include attributable EBITDA from equity investments in theatre operations in international markets and any cash distributions of earnings from its other equity method investees. The measure of segment profit and loss the Company uses to evaluate performance and allocate its resources is Adjusted EBITDA, which is consistent with how Adjusted EBITDA is defined in its debt indentures. |
| (2) | Distributions from NCM are reported entirely within the U.S. markets segment. |
Three Months Ended |
Six Months Ended |
|||||||||||
Capital Expenditures (In millions) |
|
June 30, 2019 |
|
June 30, 2018 |
June 30, 2019 |
|
June 30, 2018 |
|||||
U.S. markets |
$ |
|
$ |
|
$ |
|
$ |
|
||||
International markets |
|
|
|
|
||||||||
Total capital expenditures |
$ |
|
$ |
|
$ |
|
$ |
|
||||
Financial Information About Geographic Area:
Three Months Ended |
Six Months Ended |
|||||||||||
Revenues (In millions) |
June 30, 2019 |
June 30, 2018 |
June 30, 2019 |
|
June 30, 2018 |
|||||||
United States |
$ |
|
$ |
|
$ |
|
$ |
|
||||
United Kingdom |
|
|
|
|
||||||||
Spain |
|
|
|
|
||||||||
Sweden |
|
|
|
|
||||||||
Italy |
|
|
|
|
||||||||
Germany |
|
|
|
|
||||||||
Finland |
|
|
|
|
||||||||
Ireland |
|
|
|
|
||||||||
Other foreign countries |
|
|
|
|
||||||||
Total |
$ |
|
$ |
|
$ |
|
$ |
|
||||
As of |
As of |
|||||
Long-term assets, net (In millions) |
June 30, 2019 |
December 31, 2018 |
||||
United States |
$ |
|
$ |
|
||
International |
|
|
||||
Total long-term assets (1) |
$ |
|
$ |
|
||
| (1) | Long-term assets are comprised of property, intangible assets, goodwill, deferred income tax assets and other long-term assets, and for 2019, right-of-use assets. |
33
The following table sets forth a reconciliation of net earnings (loss) to Adjusted EBITDA:
Three Months Ended |
Six Months Ended |
|||||||||||
(In millions) |
June 30, 2019 |
June 30, 2018 |
|
June 30, 2019 |
June 30, 2018 |
|||||||
Net earnings (loss) |
$ |
|
$ |
|
$ |
( |
$ |
|
||||
Plus: |
||||||||||||
Income tax provision (benefit) |
|
|
|
( |
|
|
|
|
||||
Interest expense |
|
|
|
|
|
|
|
|
||||
Depreciation and amortization |
|
|
|
|
|
|
|
|
||||
Certain operating expenses (1) |
|
|
|
|
|
|
|
|
||||
Equity in earnings of non-consolidated entities (2) |
|
( |
|
( |
|
( |
|
( |
||||
Cash distributions from non-consolidated entities (3) |
|
|
|
|
|
|
|
|
||||
Attributable EBITDA (4) |
|
( |
|
|
||||||||
Investment income |
|
( |
|
( |
|
( |
|
( |
||||
Other expense (income) (5) |
|
( |
|
|
|
|
|
|
||||
Non-cash rent - purchase accounting (6) |
|
— |
|
— |
||||||||
General and administrative — unallocated: |
||||||||||||
Merger, acquisition and transaction costs (7) |
|
|
|
|
|
|
|
|
||||
Stock-based compensation expense (8) |
|
|
|
|
|
|
|
|
||||
Adjusted EBITDA |
$ |
|
$ |
|
$ |
|
$ |
|
||||
| (1) | Amounts represent preopening expense related to temporarily closed screens under renovation, theatre and other closure expense for the permanent closure of screens including the related accretion of interest, non-cash deferred digital equipment rent expense, and disposition of assets and other non-operating gains or losses included in operating expenses. The Company has excluded these items as they are non-cash in nature, include components of interest cost for the time value of money or are non-operating in nature. |
| (2) |
During the three months ended June 30, 2019, the Company recorded $ |
| (3) | Includes U.S. non-theatre distributions from equity method investments and International non-theatre distributions from equity method investments to the extent received. The Company believes including cash distributions is an appropriate reflection of the contribution of these investments to its operations. |
| (4) | Attributable EBITDA includes the EBITDA from equity investments in theatre operators in certain international markets. See below for a reconciliation of the Company’s equity loss of non-consolidated entities to attributable EBITDA. Because these equity investments are in theatre operators in regions where the Company holds a significant market share, the Company believes attributable EBITDA is more indicative of the performance of these equity investments and management uses this measure to monitor and evaluate these equity investments. The Company also provides services to these theatre operators including information technology systems, certain on-screen advertising services and its gift card and package ticket program. |
34
Three Months Ended |
Six Months Ended |
|||||||||||
(In millions) |
June 30, 2019 |
|
June 30, 2018 |
|
June 30, 2019 |
|
June 30, 2018 |
|||||
Equity in earnings of non-consolidated entities |
$ |
( |
$ |
( |
$ |
( |
$ |
( |
||||
Less: |
||||||||||||
Equity in earnings of non-consolidated entities excluding International theatre JV's |
( |
( |
( |
( |
||||||||
Equity in earnings (loss) of International theatre JV's |
|
( |
|
|
||||||||
Income tax provision |
|
— |
|
— |
||||||||
Investment income |
( |
— |
( |
— |
||||||||
Interest expense |
|
— |
|
— |
||||||||
Depreciation and amortization |
|
|
|
|
||||||||
Attributable EBITDA |
$ |
|
$ |
( |
$ |
|
$ |
|
||||
| (5) |
Other income for the three months ended June 30, 2019 includes income of $ |
| (6) | Reflects amortization of certain intangible assets reclassified from depreciation and amortization to rent expense, due to the adoption of ASC 842. |
| (7) | Merger, acquisition and transition costs are excluded as they are non-operating in nature. |
| (8) | Stock-based compensation expense is non-cash expense included in general and administrative: other. |
NOTE 12—COMMITMENTS AND CONTINGENCIES
The Company, in the normal course of business, is a party to various ordinary course claims from vendors (including food and beverage suppliers and film distributors), landlords, competitors, and other legal proceedings. If management believes that a loss arising from these actions is probable and can reasonably be estimated, the Company records the amount of the loss, or the minimum estimated liability when the loss is estimated using a range and no point is more probable than another. As additional information becomes available, any potential liability related to these actions is assessed and the estimates are revised, if necessary. Management believes that the ultimate outcome of such matters discussed below, individually and in the aggregate, will not have a material adverse effect on the Company’s financial position or overall trends in results of operations. However, litigation and claims are subject to inherent uncertainties and unfavorable outcomes can occur. An unfavorable outcome might include monetary damages. If an unfavorable outcome were to occur, there exists the possibility of a material adverse impact on the results of operations in the period in which the outcome occurs or in future periods.
On January 12, 2018 and January 19, 2018,
35
On January 22, 2019, the defendants moved to dismiss the Second Amended Class Action Complaint.
On May 21, 2018, a stockholder derivative complaint, captioned Gantulga v. Aron, et al., Case No. 2:18-cv-02262-JAR-TJJ (the “Gantulga Action”), was filed against certain of the Company’s officers and directors in the U.S. District Court for the District of Kansas. The Gantulga Action, which was filed on behalf of the Company, asserts claims under Section 14(a) of the Securities Exchange Act of 1934 and for breaches of fiduciary duty and unjust enrichment based on allegations substantially similar to the Actions. On August 27, 2018, defendants and the Company as nominal defendant filed a motion to dismiss or, in the alternative, to transfer the action to the U.S. District Court for the Southern District of New York. On September 17, 2018, plaintiff filed an amended complaint. On October 12, 2018, the parties filed a joint motion to transfer the action to the U.S. District Court for the Southern District of New York, which the court granted on October 15, 2018. When the action was transferred to the Southern District of New York, it was re-captioned Gantulga v. Aron, et al., Case No. 1:18-cv-10007-AJN. The parties filed a joint stipulation to stay the action, which the court granted on December 17, 2018.
On April 22, 2019, a putative stockholder class and derivative complaint, captioned Lao v. Dalian Wanda Group Co., Ltd., et al., C.A. No. 2019-0303-JRS (the “Lao Action”), was filed against certain of the Company’s directors, Dalian Wanda Group Co., Ltd. (“Wanda”), two of Wanda’s affiliates, Silver Lake Group, L.L.C. (“Silver Lake”), and one of Silver Lake’s affiliates in the Delaware Court of Chancery. The Lao Action asserts claims directly, on behalf of a putative class of Company stockholders, and derivatively, on behalf of the Company, for breaches of fiduciary duty and aiding and abetting breaches of fiduciary duty with respect to transactions that the Company entered into with affiliates of Wanda and Silver Lake on September 14, 2018, and the special cash dividend of $
The Company remains contingently liable for lease payments under certain leases of theatres that it previously divested, in the event that such assignees are unable to fulfill their future lease payment obligations. Due to the variety of remedies available, the Company believes that if the current tenant defaulted on the leases it would not have a material effect on the Company’s financial condition, results of operations or cash flows.
36
NOTE 13—EARNINGS (LOSS) PER SHARE
Basic net earnings (loss) per share is computed by dividing net earnings (loss) by the weighted-average number of common shares outstanding. Diluted earnings per share includes the effects of unvested RSU’s with a service condition only and unvested contingently issuable RSUs that have service and performance conditions, if dilutive, as well as potential dilutive shares from the conversion feature of the Convertible Notes due 2024, if dilutive.
The following table sets forth the computation of basic and diluted earnings (loss) per common share:
Three Months Ended |
Six Months Ended |
|||||||||||
(In millions) |
|
June 30, 2019 |
|
June 30, 2018 |
|
June 30, 2019 |
|
June 30, 2018 |
||||
Numerator: |
||||||||||||
Net earnings (loss) for basic earnings (loss) per share |
$ |
|
$ |
|
$ |
( |
$ |
|
||||
Calculation of Net earnings for diluted earnings (loss) per share: |
||||||||||||
Marked-to-market gain on derivative liability |
( |
— |
— |
— |
||||||||
Interest expense for Convertible Notes due 2024 |
|
— |
— |
— |
||||||||
Net earnings (loss) for diluted earnings (loss) per share |
$ |
|
$ |
|
$ |
( |
$ |
|
||||
Denominator (shares in thousands): |
||||||||||||
Weighted average shares for basic earnings (loss) per common share |
|
|
|
|
|
|
|
|
||||
Common equivalent shares for RSUs and PSUs |
|
|
|
|
|
— |
|
— |
||||
Common equivalent shares if converted: convertible notes 2024 |
|
— |
— |
— |
||||||||
Weighted average shares for diluted earnings (loss) per common share |
|
|
|
|
|
|
|
|
||||
Basic earnings (loss) per common share |
$ |
|
$ |
|
$ |
( |
$ |
|
||||
Diluted earnings (loss) per common share |
$ |
|
$ |
|
$ |
( |
$ |
|
||||
Vested RSUs and PSU’s have dividend rights identical to the Company’s Class A and Class B common stock and are treated as outstanding shares for purposes of computing basic and diluted earnings per share. Certain unvested RSUs and unvested PSUs are subject to performance conditions and are included in diluted earnings per share, if dilutive, based on the number of shares, if any, that would be issuable under the terms of the Company’s 2013 Equity Incentive Plan if the end of the reporting period were the end of the contingency period. During the six months ended June 30, 2019, unvested PSU’s of
During the six months ended June 30, 2018, unvested PSU’s of
The Company uses the if-converted method for calculating any potential dilutive effect of the Convertible Notes due 2024 that were issued on September 14, 2018. The Company has not adjusted net loss for the six months ended June 30, 2019 to eliminate the interest expense and the gain for the derivative liability related to the Convertible Notes due 2024 of $
37
NOTE 14—CONDENSED CONSOLIDATING FINANCIAL INFORMATION
The accompanying condensed consolidating financial information has been prepared and presented pursuant to SEC Regulation S-X Rule 3-10, Financial statements of guarantors and issuers of guaranteed securities registered or being registered. Each of the subsidiary guarantors are
The condensed consolidating information for the guarantors/non-guarantors has been retrospectively revised based on the structure that exists as of June 30, 2019 and reflecting changes as a result of the Sixth Amendment.
Condensed Consolidating Statement of Operations
Three Months Ended June 30, 2019:
Subsidiary |
Subsidiary |
Consolidating |
Consolidated |
||||||||||||
(In millions) |
Holdings |
Guarantors |
Non-Guarantors |
Adjustments |
Holdings |
||||||||||
Revenues |
|
|
|
|
|
||||||||||
Admissions |
$ |
— |
$ |
|
$ |
|
$ |
— |
$ |
|
|||||
Food and beverage |
|
— |
|
|
|
|
|
— |
|
|
|||||
Other theatre |
|
— |
|
|
|
|
|
— |
|
|
|||||
Total revenues |
|
— |
|
|
|
|
|
— |
|
|
|||||
Operating costs and expenses |
|||||||||||||||
Film exhibition costs |
|
— |
|
|
|
|
|
— |
|
|
|||||
Food and beverage costs |
|
— |
|
|
|
|
|
— |
|
|
|||||
Operating expense, excluding depreciation and amortization |
|
— |
|
|
|
|
|
— |
|
|
|||||
Rent |
|
— |
|
|
|
|
|
— |
|
|
|||||
General and administrative: |
|||||||||||||||
Merger, acquisition and transaction costs |
|
— |
|
|
|
|
|
— |
|
|
|||||
Other, excluding depreciation and amortization |
|
— |
|
|
|
|
|
— |
|
|
|||||
Depreciation and amortization |
|
— |
|
|
|
|
|
— |
|
|
|||||
Operating costs and expenses |
|
— |
|
|
|
|
|
— |
|
|
|||||
Operating income |
|
— |
|
|
|
|
|
— |
|
|
|||||
Other expense (income): |
|||||||||||||||
Equity in net loss of subsidiaries |
|
|
|
|
|
— |
|
( |
|
— |
|||||
Other expense (income) |
( |
|
( |
— |
( |
||||||||||
Interest expense: |
|||||||||||||||
Corporate borrowings |
|
|
|
|
|
|
|
( |
|
|
|||||
Capital and financing lease obligations |
|
— |
|
|
|
|
|
— |
|
|
|||||
Non-cash NCM exhibitor service agreement |
— |
|
— |
— |
|
||||||||||
Intercompany interest expense |
— |
— |
|
( |
— |
||||||||||
Equity in earnings of non-consolidated entities |
|
— |
|
( |
|
( |
|
— |
|
( |
|||||
Investment income |
|
( |
|
( |
|
( |
|
|
|
( |
|||||
Total other expense (income) |
|
( |
|
|
|
|
|
( |
|
|
|||||
Earnings (loss) before income taxes |
|
|
|
( |
|
( |
|
|
|
|
|||||
Income tax provision (benefit) |
|
— |
|
|
|
( |
|
— |
|
|
|||||
Net earnings (loss) |
$ |
|
$ |
( |
$ |
( |
$ |
|
$ |
|
|||||
38
Condensed Consolidating Statement of Operations
Three Months Ended June 30, 2018:
Subsidiary |
Subsidiary |
Consolidating |
Consolidated |
||||||||||||
(In millions) |
Holdings |
Guarantors |
Non-Guarantors |
Adjustments |
Holdings |
||||||||||
Revenues |
|
|
|
|
|
|
|
|
|
|
|||||
Admissions |
$ |
— |
$ |
|
$ |
|
$ |
— |
$ |
|
|||||
Food and beverage |
|
— |
|
|
|
|
|
— |
|
|
|||||
Other theatre |
|
— |
|
|
|
|
|
— |
|
|
|||||
Total revenues |
|
— |
|
|
|
|
|
— |
|
|
|||||
Operating costs and expenses |
|||||||||||||||
Film exhibition costs |
|
— |
|
|
|
|
|
— |
|
|
|||||
Food and beverage costs |
|
— |
|
|
|
|
|
— |
|
|
|||||
Operating expense, excluding depreciation and amortization |
|
— |
|
|
|
|
|
— |
|
|
|||||
Rent |
|
— |
|
|
|
|
|
— |
|
|
|||||
General and administrative: |
|||||||||||||||
Merger, acquisition and transaction costs |
|
— |
|
|
|
|
|
— |
|
|
|||||
Other, excluding depreciation and amortization |
|
— |
|
|
|
|
|
— |
|
|
|||||
Depreciation and amortization |
|
— |
|
|
|
|
|
— |
|
|
|||||
Operating costs and expenses |
|
— |
|
|
|
|
|
— |
|
|
|||||
Operating income (loss) |
|
— |
|
|
|
( |
|
— |
|
|
|||||
Other expense (income): |
|||||||||||||||
Equity in net (earnings) loss of subsidiaries |
|
( |
|
|
|
— |
|
|
|
— |
|||||
Other expense |
|
|
|
— |
|
||||||||||
Interest expense: |
|||||||||||||||
Corporate borrowings |
|
|
|
|
|
|
|
( |
|
|
|||||
Capital and financing lease obligations |
|
— |
|
|
|
|
|
— |
|
|
|||||
Non-cash NCM exhibitor service agreement |
— |
|
— |
|
|||||||||||
Equity in (earnings) loss of non-consolidated entities |
|
— |
|
( |
|
|
|
— |
|
( |
|||||
Investment income |
|
( |
|
( |
|
( |
|
|
|
( |
|||||
Total other expense (income) |
|
( |
|
|
|
|
|
|
|
|
|||||
Earnings (loss) before income taxes |
|
|
|
|
|
( |
|
( |
|
|
|||||
Income tax provision (benefit) |
|
— |
|
|
|
( |
|
— |
|
( |
|||||
Net earnings (loss) |
$ |
|
$ |
|
$ |
( |
$ |
( |
$ |
|
|||||
39
Condensed Consolidating Statement of Operations
Six Months Ended June 30, 2019:
Subsidiary |
Subsidiary |
Consolidating |
Consolidated |
||||||||||||
(In millions) |
Holdings |
Guarantors |
Non-Guarantors |
Adjustments |
Holdings |
||||||||||
Revenues |
|
|
|
|
|
|
|
|
|
|
|||||
Admissions |
$ |
— |
$ |
|
$ |
|
$ |
— |
$ |
|
|||||
Food and beverage |
|
— |
|
|
|
|
|
— |
|
|
|||||
Other theatre |
|
— |
|
|
|
|
|
— |
|
|
|||||
Total revenues |
|
— |
|
|
|
|
|
— |
|
|
|||||
Operating costs and expenses |
|||||||||||||||
Film exhibition costs |
|
— |
|
|
|
|
|
— |
|
|
|||||
Food and beverage costs |
|
— |
|
|
|
|
|
— |
|
|
|||||
Operating expense, excluding depreciation and amortization |
|
— |
|
|
|
|
|
— |
|
|
|||||
Rent |
|
— |
|
|
|
|
|
— |
|
|
|||||
General and administrative: |
|||||||||||||||
Merger, acquisition and transaction costs |
|
— |
|
|
|
|
|
— |
|
|
|||||
Other, excluding depreciation and amortization |
|
— |
|
|
|
|
|
— |
|
|
|||||
Depreciation and amortization |
|
— |
|
|
|
|
|
— |
|
|
|||||
Operating costs and expenses |
|
— |
|
|
|
|
|
— |
|
|
|||||
Operating income (loss) |
|
— |
|
|
|
( |
|
— |
|
|
|||||
Other expense (income): |
|||||||||||||||
Equity in net loss of subsidiaries |
|
|
|
|
|
— |
|
( |
|
— |
|||||
Other expense (income) |
( |
|
|
— |
|
||||||||||
Interest expense: |
|||||||||||||||
Corporate borrowings |
|
|
|
|
|
|
|
( |
|
|
|||||
Capital and financing lease obligations |
|
— |
|
|
|
|
|
— |
|
|
|||||
Non-cash NCM exhibitor service agreement |
— |
|
— |
— |
|
||||||||||
Intercompany interest expense |
— |
— |
|
( |
— |
||||||||||
Equity in earnings of non-consolidated entities |
|
— |
|
( |
|
( |
|
— |
|
( |
|||||
Investment income |
|
( |
|
( |
|
( |
|
|
|
( |
|||||
Total other expense (income) |
|
|
|
|
|
|
|
( |
|
|
|||||
Loss before income taxes |
|
( |
|
( |
|
( |
|
|
|
( |
|||||
Income tax provision |
|
— |
|
|
|
|
|
— |
|
|
|||||
Net loss |
$ |
( |
$ |
( |
$ |
( |
$ |
|
$ |
( |
|||||
40
Condensed Consolidating Statement of Operations
Six Months Ended June 30, 2018:
Subsidiary |
Subsidiary |
Consolidating |
Consolidated |
||||||||||||
(In millions) |
Holdings |
Guarantors |
Non-Guarantors |
Adjustments |
Holdings |
||||||||||
Revenues |
|
|
|
|
|
|
|
|
|
|
|||||
Admissions |
$ |
— |
$ |
|
$ |
|
$ |
— |
$ |
|
|||||
Food and beverage |
|
— |
|
|
|
|
|
— |
|
|
|||||
Other theatre |
|
— |
|
|
|
|
|
— |
|
|
|||||
Total revenues |
|
— |
|
|
|
|
|
— |
|
|
|||||
Operating costs and expenses |
|||||||||||||||
Film exhibition costs |
|
— |
|
|
|
|
|
— |
|
|
|||||
Food and beverage costs |
|
— |
|
|
|
|
|
— |
|
|
|||||
Operating expense, excluding depreciation and amortization |
|
— |
|
|
|
|
|
— |
|
|
|||||
Rent |
|
— |
|
|
|
|
|
— |
|
|
|||||
General and administrative: |
|||||||||||||||
Merger, acquisition and transaction costs |
|
— |
|
|
|
|
|
— |
|
|
|||||
Other, excluding depreciation and amortization |
|
— |
|
|
|
|
|
— |
|
|
|||||
Depreciation and amortization |
|
— |
|
|
|
|
|
— |
|
|
|||||
Operating costs and expenses |
|
— |
|
|
|
|
|
— |
|
|
|||||
Operating income |
|
— |
|
|
|
|
|
— |
|
|
|||||
Other expense (income): |
|||||||||||||||
Equity in net (earnings) loss of subsidiaries |
|
( |
|
|
|
— |
|
|
|
— |
|||||
Other expense |
|
|
|
— |
|
||||||||||
Interest expense: |
|||||||||||||||
Corporate borrowings |
|
|
|
|
|
|
|
( |
|
|
|||||
Capital and financing lease obligations |
|
— |
|
|
|
|
|
— |
|
|
|||||
Non-cash NCM exhibitor service agreement |
— |
|
— |
— |
|
||||||||||
Equity in earnings of non-consolidated entities |
|
— |
|
( |
|
( |
|
— |
|
( |
|||||
Investment income |
|
( |
|
( |
|
( |
|
|
|
( |
|||||
Total other expense (income) |
|
( |
|
|
|
|
|
|
|
|
|||||
Earnings (loss) before income taxes |
|
|
|
|
|
( |
|
( |
|
|
|||||
Income tax provision (benefit) |
|
— |
|
|
|
( |
|
— |
|
|
|||||
Net earnings (loss) |
$ |
|
$ |
|
$ |
( |
$ |
( |
$ |
|
|||||
41
Condensed Consolidating Statement of Comprehensive Income (Loss)
Three Months Ended June 30, 2019:
Subsidiary |
Subsidiary |
Consolidating |
Consolidated |
|
||||||||||||
(In millions) |
|
Holdings |
|
Guarantors |
|
Non-Guarantors |
|
Adjustments |
|
Holdings |
|
|||||
Net earnings (loss) |
|
$ |
|
|
$ |
( |
|
$ |
( |
|
$ |
|
|
$ |
|
|
Other comprehensive income (loss): |
||||||||||||||||
Equity in other comprehensive loss of subsidiaries |
|
( |
|
( |
|
— |
|
|
|
— |
||||||
Unrealized foreign currency translation adjustment, net of tax |
|
— |
|
( |
|
( |
|
— |
|
( |
||||||
Realized loss on foreign currency transactions reclassified into other expense, net of tax |
— |
|
— |
— |
|
|||||||||||
Pension and other benefit adjustments: |
||||||||||||||||
Net gain arising during the period, net of tax |
— |
— |
|
— |
|
|||||||||||
Equity method investees’ cash flow hedge: |
||||||||||||||||
Unrealized net holding loss arising during the period, net of tax |
|
— |
|
( |
|
— |
|
— |
|
( |
||||||
Other comprehensive loss |
|
( |
|
( |
|
( |
|
|
|
( |
||||||
Total comprehensive income (loss) |
$ |
|
$ |
( |
$ |
( |
$ |
|
$ |
|
||||||
Condensed Consolidating Statement of Comprehensive Income (Loss)
Three Months Ended June 30, 2018:
Subsidiary |
Subsidiary |
Consolidating |
Consolidated |
|
||||||||||||
(In millions) |
|
Holdings |
|
Guarantors |
|
Non-Guarantors |
|
Adjustments |
|
Holdings |
|
|||||
Net earnings (loss) |
|
$ |
|
|
$ |
|
|
$ |
( |
|
$ |
( |
|
$ |
|
|
Other comprehensive income (loss): |
||||||||||||||||
Equity in other comprehensive loss of subsidiaries |
|
( |
|
( |
|
— |
|
|
|
— |
||||||
Unrealized foreign currency translation adjustment, net of tax |
|
— |
|
( |
|
( |
|
— |
|
( |
||||||
Realized loss on foreign currency transactions reclassified into other expense, net of tax |
— |
|
— |
— |
|
|||||||||||
Pension and other benefit adjustments: |
||||||||||||||||
Net loss arising during period, net of tax |
— |
— |
( |
— |
( |
|||||||||||
Equity method investees’ cash flow hedge: |
|
|||||||||||||||
Realized net holding gain reclassified to equity in earnings of non-consolidated entities, net of tax |
|
— |
|
( |
|
— |
|
— |
|
( |
||||||
Other comprehensive loss |
|
( |
|
( |
|
( |
|
|
|
( |
||||||
Total comprehensive loss |
$ |
( |
$ |
( |
$ |
( |
$ |
|
$ |
( |
||||||
42
Condensed Consolidating Statement of Comprehensive Income (Loss)
Six Months Ended June 30, 2019:
Subsidiary |
Subsidiary |
Consolidating |
Consolidated |
|
||||||||||||
(In millions) |
|
Holdings |
|
Guarantors |
|
Non-Guarantors |
|
Adjustments |
|
Holdings |
|
|||||
Net loss |
|
$ |
( |
|
$ |
( |
|
$ |
( |
|
$ |
|
|
$ |
( |
|
Other comprehensive income (loss) |
||||||||||||||||
Equity in other comprehensive loss of subsidiaries |
|
( |
|
( |
|
— |
|
|
|
— |
||||||
Unrealized foreign currency translation adjustment, net of tax |
— |
|
( |
|
( |
|
— |
|
( |
|||||||
Realized loss on foreign currency transactions, net of tax |
|
— |
|
|
|
— |
|
— |
|
|
||||||
Pension and other benefit adjustments: |
||||||||||||||||
Net gain arising during the period, net of tax |
— |
|
— |
— |
|
|||||||||||
Equity method investees’ cash flow hedge: |
||||||||||||||||
Unrealized net holding loss arising during the period, net of tax |
|
— |
|
( |
|
— |
|
— |
|
( |
||||||
Other comprehensive loss |
|
( |
|
( |
|
( |
|
|
|
( |
||||||
Total comprehensive loss |
$ |
( |
$ |
( |
$ |
( |
$ |
|
$ |
( |
||||||
Condensed Consolidating Statement of Comprehensive Income (Loss)
Six Months Ended June 30, 2018:
Subsidiary |
Subsidiary |
Consolidating |
Consolidated |
|
||||||||||||
(In millions) |
|
Holdings |
|
Guarantors |
|
Non-Guarantors |
|
Adjustments |
|
Holdings |
|
|||||
Net earnings (loss) |
|
$ |
|
|
$ |
|
|
$ |
( |
|
$ |
( |
|
$ |
|
|
Other comprehensive income (loss) |
||||||||||||||||
Equity in other comprehensive loss of subsidiaries |
|
( |
|
( |
|
— |
|
|
|
— |
||||||
Unrealized foreign currency translation adjustment, net of tax |
|
— |
|
( |
|
( |
|
— |
|
( |
||||||
Realized loss on foreign currency transactions, net of tax |
— |
|
— |
|
||||||||||||
Pension and other benefit adjustments: |
||||||||||||||||
Net loss arising during the period, net of tax |
|
— |
|
— |
|
( |
|
— |
|
( |
||||||
Equity method investees’ cash flow hedge: |
|
|||||||||||||||
Unrealized net holding loss arising during the period, net of tax |
|
— |
|
|
|
— |
|
— |
|
|
||||||
Realized net loss reclassified to equity in earnings of non-consolidated entities, net of tax |
|
— |
|
( |
|
— |
|
— |
|
( |
||||||
Other comprehensive loss |
|
( |
|
( |
|
( |
|
|
|
( |
||||||
Total comprehensive loss |
$ |
( |
$ |
( |
$ |
( |
$ |
|
$ |
( |
||||||
43
Condensed Consolidating Balance Sheet
As of June 30, 2019:
Subsidiary |
Subsidiary |
Consolidating |
Consolidated |
||||||||||||
(In millions) |
Holdings |
Guarantors |
Non-Guarantors |
Adjustments |
Holdings |
||||||||||
Assets |
|
|
|
|
|
|
|
|
|
|
|||||
Current assets: |
|||||||||||||||
Cash and cash equivalents |
$ |
|
$ |
|
$ |
|
$ |
— |
$ |
|
|||||
Restricted cash |
— |
— |
|
— |
|
||||||||||
Receivables, net |
|
— |
|
|
|
|
|
( |
|
|
|||||
Other current assets |
|
— |
|
|
|
|
|
— |
|
|
|||||
Total current assets |
|
|
|
|
|
|
|
( |
|
|
|||||
Investment in equity of subsidiaries |
|
|
|
|
|
— |
|
( |
|
— |
|||||
Property, net |
|
— |
|
|
|
|
|
— |
|
|
|||||
Operating right-of-use assets, net |
— |
|
|
— |
|
||||||||||
Intangible assets, net |
|
— |
|
|
|
|
|
— |
|
|
|||||
Intercompany advances |
|
|
|
( |
|
( |
|
— |
|
— |
|||||
Goodwill |
|
( |
|
|
|
|
|
— |
|
|
|||||
Deferred tax asset, net |
|
— |
|
— |
|
|
|
— |
|
|
|||||
Other long-term assets |
|
|
|
|
|
|
|
— |
|
|
|||||
Total assets |
$ |
|
$ |
|
$ |
|
$ |
( |
$ |
|
|||||
Liabilities and Stockholders’ Equity |
|||||||||||||||
Current liabilities: |
|||||||||||||||
Accounts payable |
$ |
— |
$ |
|
$ |
|
$ |
( |
$ |
|
|||||
Accrued expenses and other liabilities |
|
|
|
|
|
|
|
( |
|
|
|||||
Deferred revenues and income |
|
— |
|
|
|
|
|
— |
|
|
|||||
Current maturities of corporate borrowings |
|
|
|
|
|
— |
|
— |
|
|
|||||
Current maturities of finance lease liabilities |
— |
|
|
— |
|
||||||||||
Current maturities of operating lease liabilities |
— |
|
|
— |
|
||||||||||
Total current liabilities |
|
|
|
|
|
|
|
( |
|
|
|||||
Corporate borrowings |
|
|
|
— |
|
— |
|
— |
|
|
|||||
Finance lease liabilities |
|
— |
|
|
|
|
|
— |
|
|
|||||
Operating lease liabilities |
— |
|
|
|
|||||||||||
Exhibitor services agreement |
|
— |
|
|
|
— |
|
— |
|
|
|||||
Deferred tax liability, net |
— |
|
|
— |
|
||||||||||
Other long-term liabilities |
|
— |
|
|
|
|
|
— |
|
|
|||||
Total liabilities |
|
|
|
|
|
|
|
( |
|
|
|||||
Stockholders’ equity |
|
|
|
|
|
|
|
( |
|
|
|||||
Total liabilities and stockholders’ equity |
$ |
|
$ |
|
$ |
|
$ |
( |
$ |
|
|||||
44
Condensed Consolidating Balance Sheet
As of December 31, 2018:
Subsidiary |
Subsidiary |
Consolidating |
Consolidated |
||||||||||||
(In millions) |
Holdings |
Guarantors |
Non-Guarantors |
Adjustments |
Holdings |
||||||||||
Assets |
|
|
|
|
|
|
|
|
|
|
|||||
Current assets: |
|||||||||||||||
Cash and cash equivalents |
$ |
|
$ |
|
$ |
|
$ |
— |
$ |
|
|||||
Restricted cash |
— |
— |
|
— |
|
||||||||||
Receivables, net |
|
— |
|
|
|
|
|
( |
|
|
|||||
Other current assets |
|
— |
|
|
|
|
|
— |
|
|
|||||
Total current assets |
|
|
|
|
|
|
|
( |
|
|
|||||
Investment in equity of subsidiaries |
|
|
|
|
|
— |
|
( |
|
— |
|||||
Property, net |
|
— |
|
|
|
|
|
— |
|
|
|||||
Intangible assets, net |
|
— |
|
|
|
|
|
— |
|
|
|||||
Intercompany advances |
|
|
|
( |
|
( |
|
— |
|
— |
|||||
Goodwill |
|
( |
|
|
|
|
|
— |
|
|
|||||
Deferred tax asset, net |
|
— |
|
— |
|
|
|
— |
|
|
|||||
Other long-term assets |
|
|
|
|
|
|
|
— |
|
|
|||||
Total assets |
$ |
|
$ |
|
$ |
|
$ |
( |
$ |
|
|||||
Liabilities and Stockholders’ Equity |
|||||||||||||||
Current liabilities: |
|||||||||||||||
Accounts payable |
$ |
— |
$ |
|
$ |
|
$ |
( |
$ |
|
|||||
Accrued expenses and other liabilities |
|
|
|
|
|
|
|
|
|
|
|||||
Deferred revenues and income |
|
— |
|
|
|
|
|
— |
|
|
|||||
Current maturities of corporate borrowings |
|
|
— |
— |
|
||||||||||
Current maturities of capital and financing lease obligations |
|
— |
|
|
|
|
|
— |
|
|
|||||
Total current liabilities |
|
|
|
|
|
|
|
( |
|
|
|||||
Corporate borrowings |
|
|
|
— |
|
|
|
— |
|
|
|||||
Capital and financing lease obligations |
|
— |
|
|
|
|
|
— |
|
|
|||||
Exhibitor services agreement |
|
— |
|
|
|
— |
|
— |
|
|
|||||
Deferred tax liability, net |
— |
|
|
— |
|
||||||||||
Other long-term liabilities |
|
— |
|
|
|
|
|
— |
|
|
|||||
Total liabilities |
|
|
|
|
|
|
|
( |
|
|
|||||
Temporary equity |
|
|
|
— |
|
— |
|
— |
|
|
|||||
Stockholders’ equity |
|
|
|
|
|
|
|
( |
|
|
|||||
Total liabilities and stockholders’ equity |
$ |
|
$ |
|
$ |
|
$ |
( |
$ |
|
|||||
45
Condensed Consolidating Statement of Cash Flows
Six Months Ended June 30, 2019:
Subsidiary |
Subsidiary |
Consolidating |
Consolidated |
|
||||||||||||
(In millions) |
Holdings |
Guarantors |
Non-Guarantors |
Adjustments |
Holdings |
|
||||||||||
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|
||||||
Net cash provided by (used in) operating activities |
$ |
|
$ |
( |
$ |
|
$ |
— |
$ |
|
||||||
Cash flows from investing activities: |
||||||||||||||||
Capital expenditures |
|
— |
|
( |
|
( |
|
— |
|
( |
||||||
Acquisition of theatre assets |
— |
( |
— |
— |
( |
|||||||||||
Proceeds from disposition of long-term assets |
|
— |
|
|
|
|
|
— |
|
|
||||||
Investments in non-consolidated entities, net |
|
— |
|
( |
|
— |
|
— |
|
( |
||||||
Other, net |
|
— |
|
( |
|
— |
|
— |
|
( |
||||||
Net cash used in investing activities |
|
— |
|
( |
|
( |
|
— |
|
( |
||||||
Cash flows from financing activities: |
||||||||||||||||
Proceeds from issuance of Term Loan due 2026 |
|
— |
— |
— |
|
|||||||||||
Payment of principal Senior Secured Notes due 2023 |
( |
— |
— |
— |
( |
|||||||||||
Payment of principal Senior Subordinated Notes due 2022 |
( |
— |
— |
— |
( |
|||||||||||
Call premiums paid for Senior Secured Notes due 2023 and Senior Subordinated Notes due 2022 |
( |
— |
— |
— |
( |
|||||||||||
Principal payments under Term Loans due 2022 and 2023 |
|
( |
|
— |
|
— |
|
— |
|
( |
||||||
Repayments under Revolving Credit Facility |
— |
— |
( |
— |
( |
|||||||||||
Scheduled principal payments under Term Loans |
( |
— |
— |
— |
( |
|||||||||||
Principal payments under capital and financing lease obligations |
— |
( |
( |
— |
( |
|||||||||||
Cash used to pay debt financing costs |
|
( |
|
— |
|
— |
|
— |
|
( |
||||||
Cash used to pay dividends |
|
( |
|
— |
|
— |
|
— |
|
( |
||||||
Taxes paid for restricted unit withholdings |
( |
— |
— |
— |
( |
|||||||||||
Change in intercompany advances |
( |
|
( |
— |
— |
|||||||||||
Net cash provided by (used in) financing activities |
|
( |
|
|
|
( |
|
— |
|
( |
||||||
Effect of exchange rate changes on cash and cash equivalents and restricted cash |
|
|
|
( |
|
( |
|
— |
|
( |
||||||
Net increase (decrease) in cash and cash equivalents and restricted cash |
( |
|
( |
|
( |
|
— |
|
( |
|||||||
Cash and cash equivalents and restricted cash at beginning of period |
|
|
|
|
|
|
|
— |
|
|
||||||
Cash and cash equivalents and restricted cash at end of period |
$ |
|
$ |
|
$ |
|
$ |
— |
$ |
|
||||||
46
Condensed Consolidating Statement of Cash Flows
Six Months Ended June 30, 2018:
Subsidiary |
Subsidiary |
Consolidating |
Consolidated |
||||||||||||
(In millions) |
Holdings |
Guarantors |
Non-Guarantors |
Adjustments |
Holdings |
||||||||||
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|
|||||
Net cash provided by operating activities |
$ |
|
$ |
|
$ |
|
$ |
— |
$ |
|
|||||
Cash flows from investing activities: |
|||||||||||||||
Capital expenditures |
|
— |
|
( |
|
( |
|
— |
|
( |
|||||
Proceeds from sale leaseback transactions |
— |
|
— |
— |
|
||||||||||
Proceeds from disposition of NCM, Inc. shares |
— |
|
— |
— |
|
||||||||||
Proceeds from disposition of long-term assets |
— |
|
|
— |
|
||||||||||
Investments in non-consolidated entities, net |
|
— |
|
( |
|
— |
|
— |
|
( |
|||||
Other, net |
|
— |
|
( |
|
|
|
— |
|
( |
|||||
Net cash used in investing activities |
|
— |
|
( |
|
( |
|
— |
|
( |
|||||
Cash flows from financing activities: |
|||||||||||||||
Principal payments under Term Loan |
|
( |
|
— |
|
— |
|
— |
|
( |
|||||
Principal payments under capital and financing lease obligations |
— |
( |
( |
— |
( |
||||||||||
Cash used to pay deferred financing costs |
|
( |
|
— |
|
— |
|
— |
|
( |
|||||
Cash used to pay dividends |
|
( |
|
— |
|
— |
|
— |
|
( |
|||||
Taxes paid for restricted unit withholdings |
( |
— |
— |
— |
( |
||||||||||
Purchase of treasury stock |
( |
— |
— |
— |
( |
||||||||||
Change in intercompany advances |
|
( |
( |
— |
— |
||||||||||
Net cash provided by (used in) financing activities |
|
|
|
( |
|
( |
|
— |
|
( |
|||||
Effect of exchange rate changes on cash and cash equivalents and restricted cash |
|
( |
|
|
|
|
|
— |
|
|
|||||
Net increase (decrease) in cash and cash equivalents and restricted cash |
|
|
|
|
( |
|
— |
|
|
||||||
Cash and cash equivalents and restricted cash at beginning of period |
|
|
|
|
|
|
|
— |
|
|
|||||
Cash and cash equivalents and restricted cash at end of period |
$ |
|
$ |
|
$ |
|
$ |
— |
$ |
|
|||||
47
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Forward-Looking Statements
In addition to historical information, this Quarterly Report on Form 10–Q contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “may,” “will,” “forecast,” “estimate,” “project,” “intend,” “plan,” “expect,” “should,” “believe” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. These forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors, including those discussed in “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, the following:
| ● | risks relating to motion picture production and performance; |
| ● | our lack of control over distributors of films; |
| ● | intense competition in the geographic areas in which we operate; |
| ● | increased use of alternative film delivery methods or other forms of entertainment; |
| ● | shrinking exclusive theatrical release windows; |
| ● | AMC Stubs® A-List may not meet anticipated revenue projections which could result in a negative impact upon operating results; |
| ● | general and international economic, political, social and financial market conditions and other risks including the effects of the exit of the United Kingdom from the European Union; |
| ● | risks and uncertainties relating to our significant indebtedness; |
| ● | limitations on the availability of capital may prevent us from deploying strategic initiatives and continue our share repurchase program; |
| ● | certain covenants in the agreements that govern our indebtedness may limit our ability to take advantage of certain business opportunities; |
| ● | our ability to achieve expected synergies, benefits and performance from our strategic theatre acquisitions and strategic initiatives; |
| ● | our ability to refinance our indebtedness on terms favorable to us; |
| ● | optimizing our theatre circuit through new construction and the transformation of our existing theatres may be subject to delay and unanticipated costs; |
| ● | failures, unavailability or security breaches of our information systems; |
| ● | risks relating to impairment losses, including with respect to goodwill and other intangibles, and theatre and other closure charges; |
| ● | our ability to utilize net operating loss carryforwards to reduce our future tax liability or valuation allowances taken with respect to deferred tax assets; |
48
| ● | review by antitrust authorities in connection with acquisition opportunities; |
| ● | risks relating to unexpected costs or unknown liabilities relating to recently completed acquisitions; |
| ● | risks relating to the incurrence of legal liability, including costs associated with recently filed securities class action lawsuits; |
| ● | dependence on key personnel for current and future performance and our ability to attract and retain senior executives and other key personnel, including in connection with any future acquisitions; |
| ● | risks of poor financial results may prevent us from deploying strategic initiatives; |
| ● | operating a business in international markets AMC is unfamiliar with, including acceptance by movie-goers of AMC initiatives that are new to those markets; |
| ● | increased costs in order to comply or resulting from failure to comply with governmental regulation, including the General Data Protection Regulation (“GDPR”) and pending future domestic privacy laws and regulations; and |
| ● | we may not generate sufficient cash flows or have sufficient restricted payment capacity under our Senior Secured Credit Facility or the indentures governing our debt securities to pay our intended dividends on our Class A and Class B common stock. |
This list of factors that may affect future performance and the accuracy of forward-looking statements is illustrative but not exhaustive. In addition, new risks and uncertainties may arise from time to time. Accordingly, all forward-looking statements should be evaluated with an understanding of their inherent uncertainty.
Readers are urged to consider these factors carefully in evaluating the forward-looking statements. For further information about these and other risks and uncertainties as well as strategic initiatives, see Item 1A. “Risk Factors” and Item 1. “Business” in our Annual Report on Form 10–K for the year ended December 31, 2018 and our other public filings.
All subsequent written and oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements. The forward-looking statements included herein are made only as of the date of this Quarterly Report on Form 10–Q, and we do not undertake any obligation to release publicly any revisions to such forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
Overview
AMC is the world’s largest theatrical exhibition company and an industry leader in innovation and operational excellence. We operate theatres in 15 countries and are the market leader in nine of those.
Our theatrical exhibition revenues are generated primarily from box office admissions and theatre food and beverage sales. The balance of our revenues are generated from ancillary sources, including on-screen advertising, fees earned from our AMC Stubs® customer frequency membership program, rental of theatre auditoriums, income from gift card and exchange ticket sales, on-line ticketing fees and arcade games located in theatre lobbies. As of June 30, 2019, we owned, operated or had interests in 1,004 theatres and 11,036 screens.
Film Content
Box office admissions are our largest source of revenue. We predominantly license “first-run” films from distributors owned by major film production companies and from independent distributors on a film-by-film and theatre-by-theatre basis. Film exhibition costs are accrued based on the applicable admissions revenues and estimates of the final settlement pursuant to our film licenses. Licenses that we enter into typically state that rental fees are based on aggregate terms established prior to the opening of the picture. In certain circumstances and less frequently, our rental fees are based on a mutually agreed settlement upon the conclusion of the picture. Under an aggregate terms formula, we pay the distributor a specified percentage of box office gross or pay based on a scale of percentages tied to different amounts of
49
box office gross. The settlement process allows for negotiation based upon how a film actually performs.
Our revenues attributable to individual distributors may vary significantly from year to year depending upon the commercial success of each distributor’s films in any given year. Our results of operations may vary significantly from quarter to quarter and from year to year based on the timing and popularity of film releases.
AMC Movie Screens
During the six months ended June 30, 2019, we opened four new theatres with a total of 37 screens, permanently closed 104 screens, temporarily closed 236 screens and reopened 184 screens to install consumer experience upgrades.
As of June 30, 2019, we had 5,344 3D enabled screens, including 218 IMAX®, and 113 Premium Large Format (“PLF”) screens; approximately 49% of our screens were 3D enabled screens, including IMAX® 3D enabled screens, and approximately 2% of our screens were IMAX® 3D enabled screens. The following table identifies the upgrades to our theatre circuit during the periods indicated:
|
Number of |
|
Number of |
|
|
Screens As of |
Screens As of |
|
|||
Format |
June 30, 2019 |
December 31, 2018 |
|
||
Digital |
|
11,036 |
|
11,091 |
|
3D enabled |
|
5,344 |
|
5,411 |
|
IMAX® (3D enabled) |
|
218 |
|
216 |
|
Dolby CinemaTM at AMC |
|
138 |
|
127 |
|
Other PLF (3D enabled) |
|
113 |
|
112 |
|
Dine-in theatres |
|
413 |
|
437 |
|
Premium seating |
|
3,476 |
|
3,279 |
Guest Amenities
We continually upgrade the quality of our theatre circuit through substantial renovations featuring our seating concepts, acquisitions, new builds (including expansions), expansion of food and beverage offerings (including dine-in theatres), and by disposing of older screens through closures and sales.
Recliner seating is the key feature of theatre renovations, which drive a 36% increase in attendance at these locations in their first year post renovation. These renovations, in conjunction with capital contributions from our landlords, involve stripping theatres to their basic structure in order to replace finishes throughout, upgrade the sight and sound experience, install modernized points of sale and replace traditional theatre seats with plush, electric recliners.
As of June 30, 2019, we now feature recliner seating in approximately 369 theatres, including Dine-in-Theatres, totaling approximately 3,476 screens. By the end of 2019, we expect to convert an additional 406 screens to recliner seating.
Open-source internet ticketing makes our AMC seats (over 1.1 million) in all our U.S. theatres and auditoriums, for all our showtimes as available as possible, on as many websites as possible. Our tickets are currently on sale over the internet, directly or through mobile apps, at our own website and app, Fandango, Movietickets.com, and Atom Tickets.
Food and beverage sales are our second largest source of revenue after box office admissions. Food and beverage items traditionally include popcorn, soft drinks, candy and hot dogs. Different varieties of food and beverage items are offered at our theatres based on preferences in the particular geographic region. Our traditional food and beverage strategy emphasizes prominent and appealing food and beverage offerings designed for rapid service and efficiency, including a customer friendly self-serve experience.
Our expanded menu includes enhanced food and beverage products to include made-to-order drinks and meals, customized coffee, healthy snacks, premium beers, wine and mixed drinks, flatbread pizzas, more varieties of hot dogs, four flavors of popcorn and other menu items. We currently operate 28 Dine-In Theatres that deliver chef-inspired menus with seat-side or delivery service to luxury recliners with tables.
50
AMC Stubs®
AMC Stubs® is a customer loyalty program for our U.S. markets which allows members to earn rewards, receive discounts and participate in exclusive members-only offerings and services. It features both a traditional paid tier called AMC Stubs PremiereTM and a non-paid tier called AMC Stubs InsiderTM. Both programs reward loyal guests for their patronage of AMC Theatres.
On June 26, 2018, we launched AMC Stubs® A-List, a new tier of our AMC Stubs® loyalty program. This program offers guests admission to the movies at AMC up to three times per week including multiple movies per day and repeat visits to already seen movies for $19.95 to $23.95 per month depending upon geographic market. AMC Stubs® A-List also includes premium offerings including IMAX®, Dolby Cinema™ at AMC, RealD Holdings Inc., Prime and BigD. AMC Stubs® A-List members can book tickets on-line in advance and select specific seats at AMC Theatres with reserved seating.
As of June 30, 2019, we had 20,875,000 member households in the AMC Stubs® program. AMC Stubs® members represented approximately 46% of AMC U.S. markets attendance during the three months ended June 30, 2019, driving an average 2.0x higher total gross revenue versus non-members. Our much larger database of identified movie-goers also provides us with additional insight into our customers’ movie preferences, and this enables us to have both a larger and a more targeted marketing effort to support our Hollywood studio partners.
The portion of the admissions and food and beverage revenues attributed to the rewards is deferred as a reduction of admissions and food and beverage revenues and is allocated between admissions and food and beverage revenues based on expected member redemptions.
Upon redemption, deferred rewards are recognized as revenues along with associated cost of goods. We estimate point breakage in assigning value to the points at the time of sale based on historical trends. The program’s annual membership fee is allocated to the material rights for discounted or free products and services and is initially deferred, net of estimated refunds, and recognized as the rights are redeemed based on estimated utilization, over the one-year membership period in admissions, food and beverage, and other revenues. A portion of the revenues related to a material right are deferred as a virtual rewards performance obligation using the relative standalone selling price method and are recognized as the rights are redeemed or expire.
Critical Accounting Policies and Estimates
Goodwill. We evaluate the goodwill recorded at our two reporting units (Domestic Theatres and International Theatres) for impairment annually as of the beginning of the fourth fiscal quarter or more frequently as specific events or circumstances dictate. Prior to calendar 2019 we evaluated our recorded goodwill for impairment at three reporting units (Domestic Theatres, Odeon Theatres and Nordic Theatres). Our market capitalization has been below carrying value since May 24, 2019.
A decline in our common stock price and the resulting impact on market capitalization is one of several events and circumstances we consider when determining if goodwill should be evaluated for impairment at an interim period.
51
The following table sets forth the historical closing prices per share of our Class A common stock for the calendar periods indicated:
Closing |
|||
Date |
Price Per Share |
||
July 31, 2017 |
$ |
20.40 |
|
August 31, 2017 |
13.40 |
||
September 30, 2017 |
14.70 |
||
October 31, 2017 |
13.90 |
||
November 30, 2017 |
14.25 |
||
December 31, 2017 |
15.10 |
||
January 31, 2018 |
12.80 |
||
February 28, 2018 |
15.00 |
||
March 31, 2018 |
14.05 |
||
April 30, 2018 |
17.45 |
||
May 31, 2018 |
14.80 |
||
June 30, 2018 |
15.90 |
||
July 31, 2018 |
16.30 |
||
August 31, 2018 |
19.05 |
||
September 30, 2018 |
20.50 |
||
October 31, 2018 |
19.26 |
||
November 30, 2018 |
13.65 |
||
December 31, 2018 |
12.28 |
||
January 31, 2019 |
14.65 |
||
February 28, 2019 |
14.03 |
||
March 31, 2019 |
14.85 |
||
April 30, 2019 |
15.16 |
||
May 31, 2019 |
11.98 |
||
June 30, 2019 |
9.33 |
||
July 31, 2019 |
11.83 |
||
August 7, 2019 |
11.35 |
||
The recent decline in the trading price of our Class A common stock was not considered to be a sustained decline and therefore is not an event that would require us to evaluate goodwill for impairment as of June 30, 2019.
We have previously performed a quantitative analysis of the goodwill recorded in our 3 reporting units (Domestic Theatres, Odeon Theatres and Nordic Theatres) for impairment as of September 30, 2017 based on declines in the trading price of our Class A common stock and poor box office performance during 2017 and, most recently for our Odeon Theatres and Nordic Theatres reporting units as of October 1, 2018, based on declines in their operating results compared to the prior year and in advance of combining Odeon Theatres and Nordic Theatres reporting units into a single reporting unit International Theatres. We have not recorded any goodwill impairment to date as a result of these evaluations.
If the current market price of our common stock does not increase from current levels in the near future, or if other events or circumstances change that would more likely than not reduce the fair value of our reporting units below their respective carrying values, all or a portion of our goodwill may be impaired in future periods. Examples of such adverse events or circumstances that could change include (i) an adverse change in macroeconomic conditions; (ii) increased cost factors that have a negative effect on our earnings and cash flows; (iii) negative or overall declining financial performance compared with our actual and projected results of relevant prior periods; and (iv) a sustained decrease in our share price. Any impairment charges that we may take in the future could be material to our results of operations and financial condition.
52
Leases. We adopted ASC Topic 842 effective January 1, 2019 and as a result our lease accounting policy has been modified as discussed in Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1. Lessees are required to recognize a right-of-use asset and a lease liability for virtually all of their leases (other than leases that meet the definition of a short-term lease). The liability is equal to the present value of lease payments. The asset is based on the liability, subject to certain adjustments, such as for lease incentives. For financial presentation purposes, a dual model was retained, requiring leases to be classified as either operating or finance leases. Operating leases result in straight-line expense (similar to operating leases under the prior accounting standard) while finance leases result in a front-loaded expense pattern (similar to capital leases under the prior accounting standard). We used our incremental borrowing rate to calculate the present value of our future operating lease payments, which was determined using a portfolio approach based on the rate of interest that we would have to pay to borrow an amount equal to the lease payments on a collateralized basis over a similar term.
Dividends. The following is a summary of dividends and dividend equivalents declared to stockholders:
|
|
|
Amount per |
|
Total Amount |
|||||
Share of |
Declared |
|||||||||
Declaration Date |
|
Record Date |
|
Date Paid |
|
Common Stock |
|
(In millions) |
||
May 3, 2019 |
June 10, 2019 |
June 24, 2019 |
$ |
0.20 |
$ |
21.3 |
||||
February 15, 2019 |
March 11, 2019 |
March 25, 2019 |
0.20 |
21.3 |
||||||
November 1, 2018 |
December 10, 2018 |
December 26, 2018 |
0.20 |
21.2 |
||||||
September 14, 2018 |
September 25, 2018 |
September 28, 2018 |
1.55 |
162.9 |
||||||
July 24, 2018 |
September 10, 2018 |
September 24, 2018 |
0.20 |
25.8 |
||||||
May 3, 2018 |
June 11, 2018 |
June 25, 2018 |
0.20 |
26.0 |
||||||
February 28, 2018 |
March 12, 2018 |
March 26, 2018 |
0.20 |
26.0 |
||||||
During the six months ended June 30, 2019 and June 30, 2018, we paid dividends and dividend equivalents of $42.6 million and $51.4 million, respectively. As of June 30, 2019, we accrued $3.8 million for the remaining unpaid dividends.
On August 2, 2019, we declared a cash dividend in the amount of $0.20 per share on our Class A and Class B common stock, payable on September 23, 2019 to stockholders of record on September 9, 2019.
Stock Repurchases. On August 3, 2017, we announced that our Board of Directors had approved a $100.0 million share repurchase program to repurchase our Class A common stock over a two-year period.
Repurchases may be made at management's discretion from time to time through open-market transactions including block purchases, through privately negotiated transactions, or otherwise over the next two years in accordance with all applicable securities laws and regulations. The extent to which AMC repurchases its shares, and the timing of such repurchases, will depend upon a variety of factors, including liquidity, capital needs of the business, market conditions, regulatory requirements, and other corporate considerations, as determined by AMC’s management team. Repurchases may be made under a Rule 10b5-1 plan, which would permit common stock to be repurchased when our management might otherwise be precluded from doing so under insider trading laws. The repurchase program does not obligate us to repurchase any minimum dollar amount or number of shares and may be suspended for periods or discontinued at any time. As of June 30, 2019, we had $44.3 million remaining available for repurchases under this plan. This program expired on August 2, 2019, we repurchased 3,695,856 shares for approximately $55.7 million and an average price of $14.87 per share.
AMC Shares Repurchased from Wanda. On September 14, 2018, we issued $600.0 million of Convertible Notes due 2024. Using proceeds from the Convertible Notes, we repurchased 24,057,143 shares at a price of $17.50 per share or $421.0 million and associated legal fees of $2.6 million. As of June 30, 2019, Wanda owns 49.85% of AMC through its 51,769,784 shares of Class B common stock. With the 3 to 1 voting rights of Class B common shares, Wanda retains voting control of AMC.
53
Operating Results
The following table sets forth our consolidated revenues, operating costs and expenses.
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|||||||||||
(In millions) |
June 30, 2019 |
|
June 30, 2018 |
|
% Change |
June 30, 2019 |
|
June 30, 2018 |
% Change |
||||||||
Revenues |
|||||||||||||||||
Admissions |
$ |
895.5 |
$ |
896.3 |
(0.1) |
% |
$ |
1,627.0 |
$ |
1,771.3 |
(8.1) |
% |
|||||
Food and beverage |
|
492.5 |
|
445.8 |
10.5 |
% |
|
861.3 |
|
851.6 |
1.1 |
% |
|||||
Other theatre |
|
118.1 |
|
100.4 |
17.6 |
% |
|
218.2 |
|
203.2 |
7.4 |
% |
|||||
Total revenues |
$ |
1,506.1 |
$ |
1,442.5 |
4.4 |
% |
$ |
2,706.5 |
$ |
2,826.1 |
(4.2) |
% |
|||||
Operating Costs and Expenses |
|||||||||||||||||
Film exhibition costs |
$ |
482.5 |
$ |
471.4 |
2.4 |
% |
$ |
847.8 |
$ |
897.9 |
(5.6) |
% |
|||||
Food and beverage costs |
|
76.4 |
|
72.2 |
5.8 |
% |
|
137.9 |
|
138.4 |
(0.4) |
% |
|||||
Operating expense, excluding depreciation and amortization below |
|
437.4 |
|
424.5 |
3.0 |
% |
|
840.2 |
|
836.4 |
0.5 |
% |
|||||
Rent |
|
245.9 |
|
199.7 |
23.1 |
% |
|
487.9 |
|
389.4 |
25.3 |
% |
|||||
General and administrative: |
|||||||||||||||||
Merger, acquisition and transaction costs |
|
3.2 |
|
4.3 |
(25.6) |
% |
|
6.5 |
|
9.0 |
(27.8) |
% |
|||||
Other, excluding depreciation and amortization below |
|
43.2 |
|
43.0 |
0.5 |
% |
|
89.4 |
|
87.2 |
2.5 |
% |
|||||
Depreciation and amortization |
|
112.0 |
|
137.7 |
(18.7) |
% |
|
225.0 |
|
268.2 |
(16.1) |
% |
|||||
Operating costs and expenses |
|
1,400.6 |
|
1,352.8 |
3.5 |
% |
|
2,634.7 |
|
2,626.5 |
0.3 |
% |
|||||
Operating income |
|
105.5 |
|
89.7 |
17.6 |
% |
|
71.8 |
|
199.6 |
(64.0) |
% |
|||||
Other expense (income): |
|||||||||||||||||
Other expense (income) |
|
(23.4) |
|
2.2 |
* |
% |
|
6.4 |
|
3.4 |
88.2 |
% |
|||||
Interest expense: |
|||||||||||||||||
Corporate borrowings |
|
74.2 |
|
62.2 |
19.3 |
% |
|
145.5 |
|
123.9 |
17.4 |
% |
|||||
Capital and financing lease obligations |
|
2.1 |
|
9.8 |
(78.6) |
% |
|
4.2 |
|
20.1 |
(79.1) |
% |
|||||
Non-cash NCM exhibitor service agreement |
10.1 |
10.4 |
(2.9) |
% |
20.3 |
20.9 |
(2.9) |
% |
|||||||||
Equity in earnings of non-consolidated entities (1) |
|
(10.2) |
|
(13.0) |
(21.5) |
% |
|
(16.7) |
|
(4.0) |
* |
% |
|||||
Investment income |
|
(2.1) |
|
(1.5) |
40.0 |
% |
|
(18.2) |
|
(6.7) |
* |
% |
|||||
Total other expense |
|
50.7 |
|
70.1 |
(27.7) |
% |
|
141.5 |
|
157.6 |
(10.2) |
% |
|||||
Earnings (loss) before income taxes |
|
54.8 |
|
19.6 |
* |
% |
|
(69.7) |
|
42.0 |
* |
% |
|||||
Income tax provision (benefit) |
|
5.4 |
|
(2.6) |
* |
% |
|
11.1 |
|
2.1 |
* |
% |
|||||
Net earnings (loss) |
$ |
49.4 |
$ |
22.2 |
* |
% |
$ |
(80.8) |
$ |
39.9 |
* |
% |
|||||
* Percentage change in excess of 100%
|
Three Months Ended |
|
Six Months Ended |
|||||
June 30, 2019 |
June 30, 2018 |
June 30, 2019 |
June 30, 2018 |
|||||
Operating Data: |
||||||||
Screen additions |
|
16 |
|
17 |
|
37 |
|
40 |
Screen acquisitions |
|
64 |
|
9 |
|
64 |
|
31 |
Screen dispositions |
|
36 |
|
44 |
|
104 |
|
134 |
Construction openings (closures), net |
|
(3) |
|
(65) |
|
(52) |
|
(118) |
Average screens (1) |
|
10,675 |
|
10,684 |
|
10,679 |
|
10,737 |
Number of screens operated |
|
11,036 |
|
10,988 |
|
11,036 |
|
10,988 |
Number of theatres operated |
|
1,004 |
|
1,005 |
|
1,004 |
|
1,005 |
Screens per theatre |
|
11.0 |
|
10.9 |
|
11.0 |
|
10.9 |
Attendance (in thousands) (1) |
|
96,955 |
|
91,245 |
|
176,780 |
|
182,177 |
| (1) | Includes consolidated theatres only and excludes screens offline due to construction. |
54
Segment Operating Results
The following table sets forth our revenues, operating costs and expenses by reportable segment.
U.S. Markets |
International Markets |
Consolidated |
||||||||||||||||
Three Months Ended |
Three Months Ended |
Three Months Ended |
||||||||||||||||
June 30, |
June 30, |
June 30, |
||||||||||||||||
(In millions) |
2019 |
2018 |
2019 |
2018 |
2019 |
2018 |
||||||||||||
Revenues |
||||||||||||||||||
Admissions |
$ |
680.7 |
$ |
694.2 |
$ |
214.8 |
$ |
202.1 |
$ |
895.5 |
$ |
896.3 |
||||||
Food and beverage |
|
401.1 |
|
369.3 |
|
91.4 |
|
76.5 |
|
492.5 |
|
445.8 |
||||||
Other theatre |
|
79.4 |
|
65.8 |
|
38.7 |
|
34.6 |
|
118.1 |
|
100.4 |
||||||
Total revenues |
1,161.2 |
1,129.3 |
344.9 |
313.2 |
1,506.1 |
1,442.5 |
||||||||||||
Operating Costs and Expenses |
||||||||||||||||||
Film exhibition costs |
390.2 |
391.4 |
92.3 |
80.0 |
482.5 |
471.4 |
||||||||||||
Food and beverage costs |
|
56.1 |
|
54.3 |
|
20.3 |
|
17.9 |
|
76.4 |
|
72.2 |
||||||
Operating expense |
|
320.9 |
|
300.6 |
|
116.5 |
|
123.9 |
|
437.4 |
|
424.5 |
||||||
Rent |
|
179.6 |
|
145.5 |
|
66.3 |
|
54.2 |
|
245.9 |
|
199.7 |
||||||
General and administrative expense: |
||||||||||||||||||
Merger, acquisition and transaction costs |
|
2.4 |
|
2.2 |
|
0.8 |
|
2.1 |
|
3.2 |
|
4.3 |
||||||
Other |
|
24.9 |
|
26.5 |
|
18.3 |
|
16.5 |
|
43.2 |
|
43.0 |
||||||
Depreciation and amortization |
|
84.2 |
|
97.2 |
|
27.8 |
|
40.5 |
|
112.0 |
|
137.7 |
||||||
Operating costs and expenses |
|
1,058.3 |
|
1,017.7 |
|
342.3 |
|
335.1 |
|
1,400.6 |
|
1,352.8 |
||||||
Operating income (loss) |
|
102.9 |
|
111.6 |
|
2.6 |
|
(21.9) |
|
105.5 |
|
89.7 |
||||||
Other expense (income): |
||||||||||||||||||
Other expense (income) |
|
(23.2) |
|
1.7 |
|
(0.2) |
|
0.5 |
|
(23.4) |
|
2.2 |
||||||
Interest expense: |
||||||||||||||||||
Corporate borrowings |
|
73.5 |
|
61.3 |
|
0.7 |
|
0.9 |
|
74.2 |
|
62.2 |
||||||
Capital and financing lease obligations |
|
0.6 |
|
4.4 |
|
1.5 |
|
5.4 |
|
2.1 |
|
9.8 |
||||||
Non-cash NCM exhibitor service agreement |
10.1 |
10.4 |
— |
— |
10.1 |
10.4 |
||||||||||||
Equity in (earnings) loss of non-consolidated entities |
|
(9.9) |
|
(13.9) |
|
(0.3) |
|
0.9 |
|
(10.2) |
|
(13.0) |
||||||
Investment (income) expense |
|
(0.2) |
|
(1.6) |
|
(1.9) |
|
0.1 |
|
(2.1) |
|
(1.5) |
||||||
Total other expense |
|
50.9 |
|
62.3 |
|
(0.2) |
|
7.8 |
|
50.7 |
|
70.1 |
||||||
Earnings (loss) before income taxes |
|
52.0 |
|
49.3 |
|
2.8 |
|
(29.7) |
|
54.8 |
|
19.6 |
||||||
Income tax provision (benefit) |
|
5.8 |
|
1.4 |
|
(0.4) |
|
(4.0) |
|
5.4 |
|
(2.6) |
||||||
Net earnings (loss) |
$ |
46.2 |
$ |
47.9 |
$ |
3.2 |
$ |
(25.7) |
$ |
49.4 |
$ |
22.2 |
||||||
U.S. Markets |
International Markets |
Consolidated |
||||||||||
Three Months Ended |
Three Months Ended |
Three Months Ended |
||||||||||
June 30, |
June 30, |
June 30, |
||||||||||
2019 |
2018 |
2019 |
2018 |
2019 |
2018 |
|||||||
Segment Operating Data: |
||||||||||||
Screen additions |
|
— |
|
17 |
16 |
— |
16 |
17 |
||||
Screen acquisitions |
|
64 |
|
9 |
— |
— |
64 |
9 |
||||
Screen dispositions |
|
28 |
|
44 |
8 |
— |
36 |
44 |
||||
Construction openings (closures), net |
|
(6) |
|
(38) |
3 |
(27) |
(3) |
(65) |
||||
Average screens (1) |
|
8,006 |
|
8,010 |
2,669 |
2,674 |
10,675 |
10,684 |
||||
Number of screens operated |
|
8,107 |
|
8,080 |
2,929 |
2,908 |
11,036 |
10,988 |
||||
Number of theatres operated |
|
639 |
|
639 |
365 |
366 |
1,004 |
1,005 |
||||
Screens per theatre |
|
12.7 |
|
12.6 |
8.0 |
7.9 |
11.0 |
10.9 |
||||
Attendance (in thousands) (1) |
|
71,900 |
|
69,751 |
25,055 |
21,494 |
96,955 |
91,245 |
||||
| (1) | Includes consolidated theatres only and excludes screens offline due to construction. |
55
U.S. Markets |
International Markets |
Consolidated |
||||||||||||||||
Six Months Ended |
Six Months Ended |
Six Months Ended |
||||||||||||||||
June 30, |
June 30, |
June 30, |
||||||||||||||||
(In millions) |
2019 |
2018 |
2019 |
2018 |
2019 |
2018 |
||||||||||||
Revenues |
||||||||||||||||||
Admissions |
$ |
1,196.1 |
$ |
1,298.9 |
$ |
430.9 |
$ |
472.4 |
$ |
1,627.0 |
$ |
1,771.3 |
||||||
Food and beverage |
|
688.7 |
|
680.8 |
|
172.6 |
|
170.8 |
|
861.3 |
|
851.6 |
||||||
Other theatre |
|
143.6 |
|
131.7 |
|
74.6 |
|
71.5 |
|
218.2 |
|
203.2 |
||||||
Total revenues |
2,028.4 |
2,111.4 |
678.1 |
714.7 |
2,706.5 |
2,826.1 |
||||||||||||
Operating Costs and Expenses |
||||||||||||||||||
Film exhibition costs |
667.5 |
707.6 |
180.3 |
190.3 |
847.8 |
897.9 |
||||||||||||
Food and beverage costs |
|
99.0 |
|
98.6 |
|
38.9 |
|
39.8 |
|
137.9 |
|
138.4 |
||||||
Operating expense |
|
606.5 |
|
582.5 |
|
233.7 |
|
253.9 |
|
840.2 |
|
836.4 |
||||||
Rent |
|
356.2 |
|
278.7 |
|
131.7 |
|
110.7 |
|
487.9 |
|
389.4 |
||||||
General and administrative expense: |
||||||||||||||||||
Merger, acquisition and transaction costs |
|
3.5 |
|
6.2 |
|
3.0 |
|
2.8 |
|
6.5 |
|
9.0 |
||||||
Other |
|
52.5 |
|
52.9 |
|
36.9 |
|
34.3 |
|
89.4 |
|
87.2 |
||||||
Depreciation and amortization |
|
167.9 |
|
191.3 |
|
57.1 |
|
76.9 |
|
225.0 |
|
268.2 |
||||||
Operating costs and expenses |
|
1,953.1 |
|
1,917.8 |
|
681.6 |
|
708.7 |
|
2,634.7 |
|
2,626.5 |
||||||
Operating income (loss) |
|
75.3 |
|
193.6 |
|
(3.5) |
|
6.0 |
|
71.8 |
|
199.6 |
||||||
Other expense (income): |
||||||||||||||||||
Other expense |
|
6.1 |
|
1.5 |
|
0.3 |
|
1.9 |
|
6.4 |
|
3.4 |
||||||
Interest expense: |
||||||||||||||||||
Corporate borrowings |
|
144.1 |
|
122.0 |
|
1.4 |
|
1.9 |
|
145.5 |
|
123.9 |
||||||
Capital and financing lease obligations |
|
1.4 |
|
9.0 |
|
2.8 |
|
11.1 |
|
4.2 |
|
20.1 |
||||||
Non-cash NCM exhibitor service agreement |
20.3 |
20.9 |
— |
— |
20.3 |
20.9 |
||||||||||||
Equity in earnings of non-consolidated entities (1) |
|
(16.0) |
|
(3.6) |
|
(0.7) |
|
(0.4) |
|
(16.7) |
|
(4.0) |
||||||
Investment income |
|
(5.3) |
|
(6.7) |
|
(12.9) |
|
— |
|
(18.2) |
|
(6.7) |
||||||
Total other expense (income) |
|
150.6 |
|
143.1 |
|
(9.1) |
|
14.5 |
|
141.5 |
|
157.6 |
||||||
Earnings (loss) before income taxes |
|
(75.3) |
|
50.5 |
|
5.6 |
|
(8.5) |
|
(69.7) |
|
42.0 |
||||||
Income tax provision (benefit) |
|
9.3 |
|
2.5 |
|
1.8 |
|
(0.4) |
|
11.1 |
|
2.1 |
||||||
Net earnings (loss) |
$ |
(84.6) |
$ |
48.0 |
$ |
3.8 |
$ |
(8.1) |
$ |
(80.8) |
$ |
39.9 |
||||||
U.S. Markets |
International Markets |
Consolidated |
||||||||||
Six Months Ended |
Six Months Ended |
Six Months Ended |
||||||||||
June 30, |
June 30, |
June 30, |
||||||||||
2019 |
2018 |
2019 |
2018 |
2019 |
2018 |
|||||||
Segment Operating Data: |
||||||||||||
Screen additions |
|
21 |
|
26 |
16 |
14 |
37 |
40 |
||||
Screen acquisitions |
|
64 |
|
23 |
— |
8 |
64 |
31 |
||||
Screen dispositions |
|
51 |
|
125 |
53 |
9 |
104 |
134 |
||||
Construction openings (closures), net |
|
(41) |
|
(68) |
(11) |
(50) |
(52) |
(118) |
||||
Average screens (1) |
|
8,003 |
|
8,053 |
2,676 |
2,684 |
10,679 |
10,737 |
||||
Number of screens operated |
|
8,107 |
|
8,080 |
2,929 |
2,908 |
11,036 |
10,988 |
||||
Number of theatres operated |
|
639 |
|
639 |
365 |
366 |
1,004 |
1,005 |
||||
Screens per theatre |
|
12.7 |
|
12.6 |
8.0 |
7.9 |
11.0 |
10.9 |
||||
Attendance (in thousands) (1) |
|
126,879 |
|
131,607 |
49,901 |
50,570 |
176,780 |
182,177 |
||||
| (1) | Includes consolidated theatres only and excludes screens offline due to construction. |
Adjusted EBITDA
We present Adjusted EBITDA as a supplemental measure of our performance. We define Adjusted EBITDA as net earnings (loss) plus (i) income tax provision (benefit), (ii) interest expense and (iii) depreciation and amortization, as further adjusted to eliminate the impact of certain items that we do not consider indicative of our ongoing operating performance and to include attributable EBITDA from equity investments in theatre operations in international markets and any cash distributions of earnings from other equity method investees. These further adjustments are itemized below. You are encouraged to evaluate these adjustments and the reasons we consider them appropriate for supplemental analysis. In evaluating Adjusted EBITDA, you should be aware that in the future we may incur expenses that are the
56
same as or similar to some of the adjustments in this presentation. Our presentation of Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items.
Adjusted EBITDA decreased by $7.2 million during the three months ended June 30, 2019 compared to the three months ended June 30, 2018. Adjusted EBITDA in U.S. markets decreased by $20.1 million primarily due to the modification of a lease in the prior year that reduced rent expense in 2018 by $10.8 million and increased rent due to the new lease standard ASC 842 that reduced Adjusted EBITDA by approximately $12.8 million. Adjusted EBITDA in international markets increased $12.9 million primarily due to increases in attendance, partially offset by increased rent due to the new lease standard ASC 842 that reduced Adjusted EBITDA by approximately $9.9 million, and a decrease in foreign currency translation rates. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.
Adjusted EBITDA decreased by $176.9 million during the six months ended June 30, 2019 compared to the six months ended June 30, 2018. Adjusted EBITDA in U.S. markets decreased by $151.0 million primarily due to decreases in attendance, the modification of a lease in the prior year that reduced rent expense in 2018 by $35.0 million and increased rent due to the new lease standard ASC 842 that reduced Adjusted EBITDA by approximately $25.6 million. Adjusted EBITDA in international markets decreased $25.9 million primarily due to increased rent due to the new lease standard ASC 842 that reduced Adjusted EBITDA by approximately $19.8 million, decreases in attendance and a decrease in foreign currency translation rates. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.
The following tables set forth our Adjusted EBITDA by reportable operating segment and our reconciliation of Adjusted EBITDA:
Three Months Ended |
Six Months Ended |
|||||||||||
Adjusted EBITDA (In millions) |
June 30, 2019 |
|
June 30, 2018 |
June 30, 2019 |
|
June 30, 2018 |
||||||
U.S. markets (1) |
$ |
202.1 |
$ |
222.2 |
$ |
279.5 |
$ |
430.5 |
||||
International markets |
35.5 |
22.6 |
66.3 |
92.2 |
||||||||
Total Adjusted EBITDA |
$ |
237.6 |
$ |
244.8 |
$ |
345.8 |
$ |
522.7 |
||||
| (1) | Distributions from NCM are reported entirely within the U.S. markets segment. |
Three Months Ended |
Six Months Ended |
|||||||||||
(In millions) |
June 30, 2019 |
June 30, 2018 |
|
June 30, 2019 |
June 30, 2018 |
|||||||
Net earnings (loss) |
$ |
49.4 |
$ |
22.2 |
$ |
(80.8) |
$ |
39.9 |
||||
Plus: |
||||||||||||
Income tax provision (benefit) |
|
5.4 |
|
(2.6) |
|
11.1 |
|
2.1 |
||||
Interest expense |
|
86.4 |
|
82.4 |
|
170.0 |
|
164.9 |
||||
Depreciation and amortization |
|
112.0 |
|
137.7 |
|
225.0 |
|
268.2 |
||||
Certain operating expenses (1) |
|
2.3 |
|
5.7 |
|
4.8 |
|
9.4 |
||||
Equity in earnings of non-consolidated entities (2) |
|
(10.2) |
|
(13.0) |
|
(16.7) |
|
(4.0) |
||||
Cash distributions from non-consolidated entities (3) |
|
1.8 |
|
3.5 |
|
12.3 |
|
27.8 |
||||
Attributable EBITDA (4) |
2.0 |
(0.4) |
2.9 |
1.6 |
||||||||
Investment income |
|
(2.1) |
|
(1.5) |
|
(18.2) |
|
(6.7) |
||||
Other expense (income) (5) |
|
(23.8) |
|
2.5 |
|
6.1 |
|
3.7 |
||||
Non-cash rent - purchase accounting (6) |
5.8 |
— |
13.4 |
— |
||||||||
General and administrative — unallocated: |
||||||||||||
Merger, acquisition and transaction costs (7) |
|
3.2 |
|
4.3 |
|
6.5 |
|
9.0 |
||||
Stock-based compensation expense (8) |
|
5.4 |
|
4.0 |
|
9.4 |
|
6.8 |
||||
Adjusted EBITDA |
$ |
237.6 |
$ |
244.8 |
$ |
345.8 |
$ |
522.7 |
||||
| (1) | Amounts represent preopening expense related to temporarily closed screens under renovation, theatre and other closure expense for the permanent closure of screens including the related accretion of interest, non-cash deferred digital equipment rent expense, and disposition of assets and other non-operating gains or losses |
57
| included in operating expenses. We have excluded these items as they are non-cash in nature, include components of interest cost for the time value of money or are non-operating in nature. |
| (2) | During the three months ended June 30, 2019, we recorded $9.0 million in earnings from DCIP. During the six months ended June 30, 2019, we recorded $14.6 million in earnings from DCIP. During the six months ended June 30, 2018, equity in earnings of non-consolidated entities includes a lower of carrying value impairment loss on the held-for-sale portion of NCM of $16.0 million. The impairment charges reflect recording our held-for-sale units and other-than-temporary impaired shares at the publicly quoted per share price on March 31, 2018 of $5.19. Equity in earnings of non-consolidated entities also includes the surrender (disposition) of a portion of our investment in NCM of $1.1 million during the six months ended June 30, 2018. |
| (3) | Includes U.S. non-theatre distributions from equity method investments and International non-theatre distributions from equity method investments to the extent received. We believe including cash distributions is an appropriate reflection of the contribution of these investments to our operations. |
| (4) | Attributable EBITDA includes the EBITDA from equity investments in theatre operators in certain international markets. See below for a reconciliation of our equity (earnings) loss of non-consolidated entities to attributable EBITDA. Because these equity investments are in theatre operators in regions where we hold a significant market share, we believe attributable EBITDA is more indicative of the performance of these equity investments and management uses this measure to monitor and evaluate these equity investments. We also provide services to these theatre operators including information technology systems, certain on-screen advertising services and our gift card and package ticket program. |
Three Months Ended |
Six Months Ended |
|||||||||||
(In millions) |
June 30, 2019 |
|
June 30, 2018 |
|
June 30, 2019 |
|
June 30, 2018 |
|||||
Equity in earnings of non-consolidated entities |
$ |
(10.2) |
$ |
(13.0) |
$ |
(16.7) |
$ |
(4.0) |
||||
Less: |
||||||||||||
Equity in earnings of non-consolidated entities excluding International theatre JV's |
(9.8) |
(13.9) |
(15.8) |
(3.6) |
||||||||
Equity in earnings (loss) of International theatre JV's |
0.4 |
(0.9) |
0.9 |
0.4 |
||||||||
Income tax provision |
0.1 |
— |
0.1 |
— |
||||||||
Investment income |
(0.3) |
— |
(0.5) |
— |
||||||||
Interest expense |
0.1 |
— |
0.1 |
— |
||||||||
Depreciation and amortization |
1.7 |
0.5 |
2.3 |
1.2 |
||||||||
Attributable EBITDA |
$ |
2.0 |
$ |
(0.4) |
$ |
2.9 |
$ |
1.6 |
||||
| (5) | Other income for the three months ended June 30, 2019 includes income of $33.9 million due to the decrease in fair value of our derivative liability for the Convertible Notes due 2024, income of $7.1 million as a result of an increase in fair value of its derivative asset, and expense of $16.6 million of fees related to modifications of term loans. Other expense for the six months ended June 30, 2019 includes income of $20.6 million due to the decrease in fair value of our derivative liability for the Convertible Notes due 2024, an expense of $8.0 million as a result of a decrease in fair value of its derivative asset, an expense of $16.6 million of fees related to modifications of term loans, and $1.0 million loss on GBP forward contract. |
| (6) | Reflects amortization of certain intangible assets reclassified from depreciation and amortization to rent expense, due to the adoption of ASC 842. |
| (7) | Merger, acquisition and transition costs are excluded as they are non-operating in nature. |
| (8) | Stock-based compensation expense is non-cash expense included in general and administrative: other |
Adjusted EBITDA is a non-GAAP financial measure commonly used in our industry and should not be construed as an alternative to net earnings (loss) as an indicator of operating performance (as determined in accordance with U.S. GAAP). Adjusted EBITDA may not be comparable to similarly titled measures reported by other companies.
58
We have included Adjusted EBITDA because we believe it provides management and investors with additional information to measure our performance and estimate our value.
Adjusted EBITDA has important limitations as an analytical tool, and you should not consider it in isolation, or as a substitute for analysis of our results as reported under U.S. GAAP. For example, Adjusted EBITDA:
| ● | does not reflect our capital expenditures, future requirements for capital expenditures or contractual commitments; |
| ● | does not reflect changes in, or cash requirements for, our working capital needs; |
| ● | does not reflect the significant interest expenses, or the cash requirements necessary to service interest or principal payments, on our debt; |
| ● | excludes income tax payments that represent a reduction in cash available to us; |
| ● | does not reflect any cash requirements for the assets being depreciated and amortized that may have to be replaced in the future; and |
| ● | does not reflect the impact of divestitures that were required in connection with recently completed acquisitions. |
Results of Operations— For the Three Months Ended June 30, 2019 and June 30, 2018
Condensed Consolidated Results of Operations
Revenues. Total revenues increased 4.4%, or $63.6 million, during the three months ended June 30, 2019 compared to the three months ended June 30, 2018. Admissions revenues decreased 0.1%, or $0.8 million during the three months ended June 30, 2019 compared to the three months ended June 30, 2018, primarily due a 5.9% decrease in average ticket price offset by a 6.2% increase in attendance. The decrease in average ticket price was primarily due to strategic pricing initiatives put in place over the last year; decreases in the popularity of IMAX premium content, and declines in foreign currency translation rates. The increase in attendance was primarily due to strategic pricing initiatives in the U.S. markets and the popularity of films in International markets.
Food and beverage revenues increased 10.5%, or $46.7 million, during the three months ended June 30, 2019 compared to the three months ended June 30, 2018, primarily due to increase in attendance and a 4.0% increase in food and beverage revenues per patron. Food and beverage revenues per patron increased as a result of strategic price increases, our food and beverage initiatives including theatre renovations, and our Feature Fare menu, partially offset by declines in foreign currency translation rates.
Total other theatre revenues increased 17.6%, or $17.7 million, during the three months ended June 30, 2019 compared to the three months ended June 30, 2018, primarily due to the increase in ticket fees, partially offset by declines in foreign currency translation rates.
Operating costs and expenses. Operating costs and expenses increased 3.5%, or $47.8 million, during the three months ended June 30, 2019 compared to the three months ended June 30, 2018. Film exhibition costs increased 2.4%, or $11.1 million, during the three months ended June 30, 2019 compared to the three months ended June 30, 2018, primarily due to the increase in attendance. As a percentage of admissions revenues, film exhibition costs were 53.9% for the three months ended June 30, 2019 and 52.6% for the three months ended June 30, 2018.
Food and beverage costs increased 5.8%, or $4.2 million, during the three months ended June 30, 2019 compared to the three months ended June 30, 2018. The increase in food and beverage costs was primarily due to the increase in food and beverage revenues. As a percentage of food and beverage revenues, food and beverage costs were 15.5% for the three months ended June 30, 2019 and 16.2% for the three months ended June 30, 2018. Food and beverage gross profit per patron increased 4.8% and is calculated as food and beverage revenues less food and beverage costs divided by attendance.
As a percentage of revenues, operating expense was 29.0% for the three months ended June 30, 2019 and
59
29.4% for the three months ended June 30, 2018. Rent expense increased 23.1%, or $46.2 million, during the three months ended June 30, 2019 compared to the three months ended June 30, 2018, primarily due to a prior year modification of a theatre lease which reduced rent by $10.8 million in 2018 and the adoption of ASC 842 for lease accounting where approximately $20.9 million of principal and interest payments were reclassified as rent expense during the three months ended June 30, 2019 related to build-to-suit financing lease obligations, $1.8 million of deferred gain amortization for sale leaseback transactions that previously reduced rent expense was eliminated and $7.7 million of non-cash expense from purchase accounting was recorded as rent expense, which was previously classified as depreciation and amortization expense. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.
Merger, acquisition and transaction costs. Merger, acquisition and transaction costs were $3.2 million during the three months ended June 30, 2019 compared to $4.3 million during the three months ended June 30, 2018, primarily due to expenses incurred in connection with the Nordic acquisition in the prior year.
Other. Other general and administrative expense increased $0.2 million during the three months ended June 30, 2019 compared to the three months ended June 30, 2018.
Depreciation and amortization. Depreciation and amortization decreased $25.7 million during the three months ended June 30, 2019 compared to the three months ended June 30, 2018, primarily due to the adoption of ASC 842 where the financing lease building and related depreciation were eliminated. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.
Other Expense (Income):
Other expense (income). Other income of $23.4 million during the three months ended June 30, 2019 is primarily due to an increase in fair value of our derivative asset for the contingent call option related to the Class B common stock purchase and cancellation agreement of $7.1 million and a decrease of $33.9 million in fair value of our derivative liability for the embedded conversion feature in our Convertible Notes due 2024 which resulted in a gain of $41.0 million, partially offset by $16.6 million of expense related to the repayment of indebtedness (See Note 6 – Corporate Borrowings for additional information). During the three months ended June 30, 2018, other expense included $0.1 million financing related foreign currency transaction losses, $0.7 million loss on forward foreign currency contracts, and $0.4 million net periodic benefit cost.
Interest expense. Interest expense increased $4.0 million to $86.4 million for the three months ended June 30, 2019 compared to $82.4 million during the three months ended June 30, 2018. The increase is primarily due to the issuance of our 2.95% $600.0 million Convertible Notes due 2024 on September 14, 2018 and our Senior Secured Credit Facility-Term Loan due 2026, partially offset by the reclassification to rent expense of $6.9 million of financing lease obligation interest as a result of the adoption of ASC 842. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.
Equity in earnings of non-consolidated entities. Equity in earnings of non-consolidated entities were $10.2 million for the three months ended June 30, 2019 compared to $13.0 million for the three months ended June 30, 2018.
Investment income. Investment income was $2.1 million for the three months ended June 30, 2019 compared to $1.5 million for the three months ended June 30, 2018. Investment income includes a gain on the sale of our Austria theatres of $1.9 million for the three months ended June 30, 2019. Investment income for the three months ended June 30, 2018 includes a $1.5 million gain on the sale of a joint venture managed theatre.
Income tax provision (benefit). The income tax provision was $5.4 million for the three months ended June 30, 2019 and the income tax benefit was $2.6 million for the three months ended June 30, 2018. See Note 8—Income Taxes of the Notes to the Condensed Consolidated Financial Statements in Item 1 of Part I of this Form 10-Q for further information.
Net earnings. Net earnings were $49.4 million and $22.2 million during the three months ended June 30, 2019 and June 30, 2018, respectively. Net earnings during the three months ended June 30, 2019 compared to the three months ended June 30, 2018 were positively impacted by higher food and beverage revenue and higher other theatre revenue, increased other income; gains related to our derivative asset and liability, decreases in depreciation and
60
amortization expense, offset by higher income tax provision, lower average ticket prices which negatively impacted admissions revenue, higher rent expense, and a decline in foreign currency translation rates.
Theatrical Exhibition–U.S. Markets
Revenues. Total revenues increased 2.8%, or $31.9 million, during the three months ended June 30, 2019 compared to the three months ended June 30, 2018. Admissions revenues decreased 1.9%, or $13.5 million, during the three months ended June 30, 2019 compared to the three months ended June 30, 2018, primarily due to a 4.9% decrease in average ticket price partially offset by a 3.1% increase in attendance. The decrease in average ticket price was primarily due to strategic pricing initiatives and decreases in premium format attendance for IMAX. Attendance increased primarily due to the popularity of films released in the quarter as compared to the same period a year ago.
Food and beverage revenues increased 8.6%, or $31.8 million, during the three months ended June 30, 2019 compared to the three months ended June 30, 2018, primarily due to the increase in attendance, and an increase in food and beverage revenues per patron of 5.4%. Food and beverage revenues per patron increased as a result of strategic price increases and our food and beverage initiatives including our Feature Fare menu and theatre renovations.
Total other theatre revenues increased 20.7%, or $13.6 million, during the three months ended June 30, 2019 compared to the three months ended June 30, 2018, primarily due to an increase in ticket fees of $10.3 million primarily due to the increase in attendance.
Operating costs and expenses. Operating costs and expenses increased 4.0%, or $40.6 million, during the three months ended June 30, 2019 compared to the three months ended June 30, 2018. Film exhibition costs decreased 0.3%, or $1.2 million, during the three months ended June 30, 2019 compared to the three months ended June 30, 2018, primarily due to the decrease in admissions revenues. As a percentage of admissions revenues, film exhibition costs were 57.3% and 56.4% for the three months ended June 30, 2019 and June 30, 2018, respectively.
Food and beverage costs increased 3.3%, or $1.8 million, during the three months ended June 30, 2019 compared to the three months ended June 30, 2018. As a percentage of food and beverage revenues, food and beverage costs were 14.0% for the three months ended June 30, 2019 and 14.7% for the three months ended June 30, 2018. Food and beverage gross profit per patron increased 6.3% and is calculated as food and beverage revenues less food and beverage costs divided by attendance.
As a percentage of revenues, operating expense was 27.6% for the three months ended June 30, 2019 and 26.6% during the three months ended June 30, 2018. Rent expense increased 23.4%, or $34.1 million, during the three months ended June 30, 2019 compared to the three months ended June 30, 2018. Rent expense increased due to a prior year modification of a theatre lease which reduced rent expense by $10.8 million and the adoption of ASC 842 for lease accounting that caused increases in cash rent expense for build-to-suit financing lease obligations of $11.0 million, non-cash rent expense – purchase accounting included in rent expense of $4.6 million and the elimination of $1.8 million of deferred gain amortization. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.
General and Administrative Expense:
Merger, acquisition and transaction costs. Merger, acquisition and transaction costs were $2.4 million during the three months ended June 30, 2019 compared to $2.2 million during the three months ended June 30, 2018, primarily due to increases in expenses incurred in connection with the acquisition of other theatre assets in the current year.
Other. Other general and administrative expense decreased $1.6 million during the three months ended June 30, 2019 compared to the three months ended June 30, 2018.
Depreciation and amortization. Depreciation and amortization decreased $13.0 million during the three months ended June 30, 2019 compared to the three months ended June 30, 2018 primarily due to the adoption of ASC 842 where the financing lease buildings and related depreciation were eliminated. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.
61
Other Expense (Income):
Other expense (income). Other income of $23.2 million during the three months ended June 30, 2019 is primarily due to an increase in fair value of our derivative asset for the contingent call option related to the Class B common stock purchase and cancellation agreement of $7.1 million and decrease of $33.9 million in fair value of our derivative liability for the embedded conversion feature in our Convertible Notes due 2024 which resulted in income of $41.0 million, partially offset by $16.6 million expense related to the repayment of indebtedness (See Note 6 – Corporate Borrowings for additional information). Other expense of $1.7 million during the three months ended June 30, 2018 is primarily due to loss on foreign currency transactions of $1.8 million, and net periodic benefit cost of $0.2 million, partially offset by $0.3 million in business interruption recoveries.
Interest expense. Interest expense increased $8.1 million to $84.2 million for the three months ended June 30, 2019 compared to $76.1 million for the three months ended June 30, 2018 primarily due to the interest expense related to our 2.95% $600.0 million Convertible Notes due 2024 issued on September 14, 2018 and our Senior Secured Credit Facility-Term Loan due 2026 issued on April 22, 2019 (See Note 6 – Corporate Borrowings), partially offset by the reclassification to rent expense of $3.3 million of financing lease obligation interest as a result of the adoption of ASC 842. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.
Equity in earnings of non-consolidated entities. Equity in earnings of non-consolidated entities were $9.9 million for the three months ended June 30, 2019 compared to $13.9 million for the three months ended June 30, 2018. Equity in earnings for the three months ended June 30, 2018 included a $2.3 million gain on the sale of NCM, Inc. common shares.
Investment income. Investment income was $0.2 million for the three months ended June 30, 2019 compared to $1.6 million for the three months ended June 30, 2018. Investment income for the three months ended June 30, 2018 includes a $1.5 million gain on the sale of a joint venture managed theatre.
Income tax provision. The income tax provision was $5.8 million and $1.4 million for the three months ended June 30, 2019 and June 30, 2018, respectively. See Note 8—Income Taxes of the Notes to the Condensed Consolidated Financial Statements in Item 1 of Part I of this Form 10-Q for further information.
Net earnings. Net earnings were $46.2 million and $47.9 million during the three months ended June 30, 2019 and June 30, 2018, respectively. Net earnings during the three months ended June 30, 2019 compared to the three months ended June 30, 2018 were decreased due to lower admissions revenue, higher rent expense, lower equity in earnings from non-consolidated entities and an increase in income tax provision, and partially offset by higher food and beverage revenues, increased other theatre revenues, decreases in depreciation and amortization expense, an increase in other income related to our derivative asset and liability.
Theatrical Exhibition - International Markets
Revenues. Total revenues increased 10.1%, or $31.7 million, during the three months ended June 30, 2019 compared to the three months ended June 30, 2018. Admissions revenues increased 6.3%, or $12.7 million, during the three months ended June 30, 2019 compared to the three months ended June 30, 2018, primarily due to an overall increase in attendance of 16.6%, partially offset by an 8.8% decline in average ticket price including declines in foreign currency translation rates. The increase in attendance was primarily due to the popularity of films released in the quarter as compared to the same period a year ago.
Food and beverage revenues increased 19.5%, or $14.9 million, during the three months ended June 30, 2019 compared to the three months ended June 30, 2018, primarily due to the overall increase in attendance and a 2.5% increase in food and beverage revenues per patron, partially offset by a decline in foreign currency translation rates.
Total other theatre revenues increased $4.1 million during the three months ended June 30, 2019 compared to the three months ended June 30, 2018, primarily due to increased screen advertising revenue, partially offset by a decline in foreign currency translation rates.
Operating costs and expenses. Operating costs and expenses increased $7.2 million during the three months ended June 30, 2019 compared to the three months ended June 30, 2018. Film exhibition costs increased $12.3 million
62
during the three months ended June 30, 2019 compared to the three months ended June 30, 2018, primarily due to the increase in admissions revenues. As a percentage of admissions revenues, film exhibition costs were 43.0% for the three months ended June 30, 2019 and 39.6% for the three months ended June 30, 2018 primarily due to the popularity of films released during the current period which typically results in higher film rent terms.
Food and beverage costs increased $2.4 million during the three months ended June 30, 2019 compared to the three months ended June 30, 2018. The increase in food and beverage costs was primarily due to the increase in food and beverage revenues. As a percentage of food and beverage revenues, food and beverage costs were 22.2% for the three months ended June 30, 2019 and 23.4% for the three months ended June 30, 2018.
As a percentage of revenues, operating expense was 33.8% for the three months ended June 30, 2019 and 39.6% during the three months ended June 30, 2018. Rent expense increased $12.1 million during the three months ended June 30, 2019 compared to the three months ended June 30, 2018 primarily due to the adoption of ASC 842 for lease accounting where approximately $9.9 million of prior year principal and interest payments were reclassified as rent expense during the three months ended June 30, 2019 related to build-to-suit financing lease obligations and $3.1 million of non-cash rent expense - purchase accounting was recorded as rent expense, offset by a decline in foreign currency translation rates. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.
General and Administrative Expense:
Merger, acquisition and transaction costs. Merger, acquisition and transaction costs decreased $1.3 million during the three months ended June 30, 2019 compared to the three months ended June 30, 2018.
Other. Other general and administrative expense increased $1.6 million, during the three months ended June 30, 2019 compared to the three months ended June 30, 2018.
Depreciation and amortization. Depreciation and amortization decreased $12.7 million during the three months ended June 30, 2019 compared to the three months ended June 30, 2018 primarily due to the adoption of ASC 842 where the financing lease buildings and depreciation were eliminated and a decline in foreign currency translation rates. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.
Interest expense. Interest expense decreased $4.1 million for the three months ended June 30, 2019 compared to the three months ended June 30, 2018, primarily due to the adoption of ASC 842 which reclassified build-to-suit finance lease obligation interest expense to rent and a decline in foreign currency translation rates. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.
Income tax benefit. The income tax benefit was $0.4 million and $4.0 million for the three months ended June 30, 2019 and June 30, 2018, respectively. See Note 8—Income Taxes of the Notes to the Condensed Consolidated Financial Statements in Item 1 of Part I of this Form 10-Q for further information.
Net earnings (loss). Net earnings increased $28.9 million during the three months ended June 30, 2019 as a result of higher attendance and the related increase in revenues, lower operating expenses, depreciation and amortization and interest expense, partially offset by a decline in foreign currency translation rates.
63
Results of Operations— For the Six Months Ended June 30, 2019 and June 30, 2018
Condensed Consolidated Results of Operations
Revenues. Total revenues decreased 4.2%, or $119.6 million, during the six months ended June 30, 2019 compared to the six months ended June 30, 2018. Admissions revenues decreased 8.1%, or $144.3 million, during the six months ended June 30, 2019 compared to the six months ended June 30, 2018, primarily due a 5.3% decrease in average ticket price and a 3.0% decrease in attendance. The decrease in average ticket price was primarily due to strategic pricing initiatives put in place over the last year; decreases in the popularity of 3D and IMAX premium content, and declines in foreign currency translation rates. The decrease in attendance was primarily due to the popularity of films (for U.S. markets and International markets) released in the first quarter as compared to the same period a year ago as well as temporary screen closures for theatre refurbishments.
Food and beverage revenues increased 1.1%, or $9.7 million, during the six months ended June 30, 2019 compared to the six months ended June 30, 2018, primarily due to a 4.2% increase in food and beverage revenues per patron, partially offset by the decrease in attendance. Food and beverage revenues per patron increased as a result of strategic price increases, our food and beverage initiatives including theatre renovations, and our Feature Fare menu, partially offset by declines in foreign currency translation rates.
Total other theatre revenues increased 7.4%, or $15.0 million, during the six months ended June 30, 2019 compared to the six months ended June 30, 2018, primarily due to increases in ticket fees, partially offset by declines in foreign currency translation rates.
Operating costs and expenses. Operating costs and expenses increased 0.3%, or $8.2 million, during the six months ended June 30, 2019 compared to the six months ended June 30, 2018. Film exhibition costs decreased 5.6%, or $50.1 million, during the six months ended June 30, 2019 compared to the six months ended June 30, 2018, primarily due to the decrease in admissions revenues. As a percentage of admissions revenues, film exhibition costs were 52.1% for the six months ended June 30, 2019 and 50.7% for the six months ended June 30, 2018.
Food and beverage costs decreased 0.4%, or $0.5 million, during the six months ended June 30, 2019 compared to the six months ended June 30, 2018. The decrease in food and beverage costs was primarily due to declines in foreign currency translation rates. As a percentage of food and beverage revenues, food and beverage costs were 16.0% for the six months ended June 30, 2019 and 16.3% for the six months ended June 30, 2018. Food and beverage gross profit per patron increased 4.5% and is calculated as food and beverage revenues less food and beverage costs divided by attendance.
As a percentage of revenues, operating expense was 31.0% for the six months ended June 30, 2019 and 29.6% for the six months ended June 30, 2018. Rent expense increased 25.3%, or $98.5 million, during the six months ended June 30, 2019 compared to the six months ended June 30, 2018, primarily due to a prior year modification of a theatre lease which reduced rent by $35.0 million in 2018 and the adoption of ASC 842 for lease accounting where approximately $41.8 million of principal and interest payments were reclassified as rent expense during the six months ended June 30, 2019 related to build-to-suit financing lease obligations, $3.6 million of deferred gain amortization for sale leaseback transactions that previously reduced rent expense was eliminated and $15.4 million of non-cash expense from purchase accounting was recorded as rent expense, which was previously classified as depreciation and amortization expense. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.
Merger, acquisition and transaction costs. Merger, acquisition and transaction costs were $6.5 million during the six months ended June 30, 2019 compared to $9.0 million during the six months ended June 30, 2018, primarily due to expenses incurred in connection with the Nordic acquisition in the prior year.
Other. Other general and administrative expense increased $2.2 million during the six months ended June 30, 2019 compared to the six months ended June 30, 2018.
Depreciation and amortization. Depreciation and amortization decreased $43.2 million during the six months ended June 30, 2019 compared to the six months ended June 30, 2018, primarily due to the adoption of ASC 842 for lease accounting where the financing lease building and related depreciation were eliminated. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.
64
Other Expense (Income):
Other expense. Other expense of $6.4 million during the six months ended June 30, 2019 is primarily due to a $16.6 million expense related to the repayment of indebtedness (See Note 6 – Corporate Borrowings for additional information), the decrease in fair value of our derivative asset for the contingent call option related to the Class B common stock purchase and cancellation agreement of $8.0 million, $1.0 million loss on forward currency contracts, offset by a decrease in fair value of our derivative liability for the embedded conversion feature in our Convertible Notes due 2024 of $20.6 million. During the six months ended June 30, 2018, other expense of $3.4 million included $1.0 million financing related foreign currency transaction losses, and $0.4 million forward foreign currency contract losses.
Interest expense. Interest expense increased $5.1 million to $170.0 million for the six months ended June 30, 2019 compared to $164.9 million during the six months ended June 30, 2018. The increase is primarily due to the issuance of our 2.95% $600.0 million Convertible Notes due 2024 on September 14, 2018 and our Senior Secured Credit Facility-Term Loan due 2026 (See Note 6 – Corporate Borrowings for additional information), partially offset by the reclassification to rent expense of $13.8 million of financing lease obligation interest as a result of the adoption of ASC 842. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.
Equity in earnings of non-consolidated entities. Equity in earnings of non-consolidated entities were $16.7 million for the six months ended June 30, 2019 compared to $4.0 million for the six months ended June 30, 2018. The earnings for the six months ended June 30, 2018 includes a $2.3 million gain on the sale of NCM, Inc. common shares, partially offset by a $16.0 million lower of carrying value or fair value impairment loss on 9,492,820 NCM units and 1,000,000 NCM, Inc. common shares held-for-sale and a $1.1 million loss on the return of 915,150 NCM units as a part of the annual common unit adjustment under the NCM ESA.
Investment income. Investment income was $18.2 million for the six months ended June 30, 2019 compared to $6.7 million for the six months ended June 30, 2018. Investment income includes a gain on the sale of our Austria theatres of $12.9 million for the six months ended June 30, 2019 and includes payments received related to the NCM tax receivable agreement of $4.0 million and $5.4 million for the six months ended June 30, 2019 and June 30, 2018, respectively. Investment income for the six months ended June 30, 2018 includes a $1.5 million gain on the sale of a joint venture managed theatre.
Income tax provision. The income tax provision was $11.1 million and $2.1 million for the six months ended June 30, 2019 and June 30, 2018, respectively. See Note 8—Income Taxes of the Notes to the Condensed Consolidated Financial Statements in Item 1 of Part I of this Form 10-Q for further information.
Net earnings (loss). Net loss was $80.8 million and net earnings were $39.9 million during the six months ended June 30, 2019 and June 30, 2018, respectively. Net loss during the six months ended June 30, 2019 compared to the six months ended June 30, 2018 was impacted by lower attendance which negatively impacted admissions revenue, higher rent expense, increased other expense related to our repayment of indebtedness, increased income tax provision, and a decline in foreign currency translation rates, offset by decreases in depreciation and amortization expense and increased equity in earnings from non-consolidated entities and increased investment income.
Theatrical Exhibition–U.S. Markets
Revenues. Total revenues decreased 3.9%, or $83.0 million, during the six months ended June 30, 2019 compared to the six months ended June 30, 2018. Admissions revenues decreased 7.9%, or $102.8 million, during the six months ended June 30, 2019 compared to the six months ended June 30, 2018, primarily due to a 4.5% decrease in average ticket price and a 3.6% decrease in attendance. The decrease in average ticket price was primarily due to strategic pricing initiatives and decreases in premium format attendance for 3D and IMAX. The decrease in attendance was primarily due to the popularity of films released in the first quarter as compared to the same period a year ago as well as temporary screen closures for theatre refurbishments.
Food and beverage revenues increased 1.2%, or $7.9 million, during the six months ended June 30, 2019 compared to the six months ended June 30, 2018, primarily due to the increase in food and beverage revenues per patron
65
of 4.9%, partially offset by the decrease in attendance. Food and beverage revenues per patron increased as a result of strategic price increases and our food and beverage initiatives including our Feature Fare menu and theatre renovations.
Total other theatre revenues increased 9.0%, or $11.9 million, during the six months ended June 30, 2019 compared to the six months ended June 30, 2018, primarily due to increased ticket fees of $8.4 million or 15.5%.
Operating costs and expenses. Operating costs and expenses increased 1.8%, or $35.3 million, during the six months ended June 30, 2019 compared to the six months ended June 30, 2018. Film exhibition costs decreased 5.7%, or $40.1 million, during the six months ended June 30, 2019 compared to the six months ended June 30, 2018, primarily due to the decrease in admissions revenues. As a percentage of admissions revenues, film exhibition costs were 55.8% and 54.5% for the six months ended June 30, 2019 and June 30, 2018, respectively.
Food and beverage costs increased 0.4%, or $0.4 million, during the six months ended June 30, 2019 compared to the six months ended June 30, 2018. As a percentage of food and beverage revenues, food and beverage costs were 14.4% for the six months ended June 30, 2019 and 14.5% for the six months ended June 30, 2018. Food and beverage gross profit per patron increased 5.0% and is calculated as food and beverage revenues less food and beverage costs divided by attendance.
As a percentage of revenues, operating expense was 29.9% for the six months ended June 30, 2019 and 27.6% during the six months ended June 30, 2018. Rent expense increased 27.8%, or $77.5 million, during the six months ended June 30, 2019 compared to the six months ended June 30, 2018. Rent expense increased due to a prior year modification of a theatre lease which reduced rent expense by $35.0 million and the adoption of ASC 842 for lease accounting that caused increases in cash rent expense for build-to-suit financing lease obligations of $22.0 million, non-cash rent expense – purchase accounting included in rent expense of $9.2 million and eliminated $3.6 million of deferred gain amortization. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.
General and Administrative Expense:
Merger, acquisition and transaction costs. Merger, acquisition and transaction costs were $3.5 million during the six months ended June 30, 2019 compared to $6.2 million during the six months ended June 30, 2018, primarily due to expenses incurred in connection with the Nordic acquisition in the prior year.
Other. Other general and administrative expense decreased $0.4 million, during the six months ended June 30, 2019 compared to the six months ended June 30, 2018.
Depreciation and amortization. Depreciation and amortization decreased $23.4 million during the six months ended June 30, 2019 compared to the six months ended June 30, 2018, primarily due to the adoption of ASC 842 for lease accounting where the financing lease buildings and related depreciation were eliminated. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.
Other Expense:
Other expense. Other expense of $6.1 million during the six months ended June 30, 2019 is primarily due to a $16.6 million expense related to the repayment of indebtedness (See Note 6 – Corporate Borrowings for additional information), a decrease in fair value of our derivative asset for the contingent call option related to the Class B common stock purchase and cancellation agreement of $8.0 million, $1.0 million loss on forward currency contracts, and partially offset by a decrease in fair value of our derivative liability for the embedded conversion feature in our Convertible Notes due 2024 which resulted in income of $20.6 million. Other expense in the prior year was primarily due to foreign currency transaction losses.
Interest expense. Interest expense increased $13.9 million to $165.8 million for the six months ended June 30, 2019 compared to $151.9 million the six months ended June 30, 2018 primarily due to the interest expense related to our 2.95% $600.0 million Convertible Notes due 2024 issued on September 14, 2018 and our Senior Secured Credit Facility-Term Loan due 2026 (See Note 6 – Corporate Borrowings for additional information), partially offset by the reclassification to rent expense of $6.6 million of financing lease obligation interest as a result of the adoption of ASC 842. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.
66
Equity in earnings of non-consolidated entities. Equity in earnings of non-consolidated entities were $16.0 million for the six months ended June 30, 2019 compared to $3.6 million for the six months ended June 30, 2018. Equity in earnings for the six months ended June 30, 2018 includes a $2.3 million gain on the sale of NCM, Inc. common shares, partially offset by a $16.0 million lower of carrying value or fair value impairment loss on 9,492,820 NCM units and 1,000,000 NCM, Inc. common shares held-for-sale and a $1.1 million loss on the return of 915,150 NCM units as a part of the annual common unit adjustment under the NCM ESA.
Investment income. Investment income was $5.3 million for the six months ended June 30, 2019 compared to $6.7 million for the six months ended June 30, 2018. Investment income includes payments received related to the NCM tax receivable agreement of $4.0 million and $5.4 million for the six months ended June 30, 2019 and June 30, 2018, respectively. Investment income for the six months ended June 30, 2018 includes a $1.5 million gain on the sale of a joint venture managed theatre.
Income tax provision. The income tax provision was $9.3 million and $2.5 million for the six months ended June 30, 2019 and June 30, 2018, respectively. See Note 8—Income Taxes of the Notes to the Condensed Consolidated Financial Statements in Item 1 of Part I of this Form 10-Q for further information.
Net earnings (loss). Net loss was $84.6 million and net earnings were $48.0 million during the six months ended June 30, 2019 and June 30, 2018, respectively. Net loss during the six months ended June 30, 2019 compared to the six months ended June 30, 2018 was impacted by lower attendance which negatively impacted admissions revenue, higher rent expense, increased other expense related to repayment of indebtedness, increased income tax provision, offset by decreases in depreciation and amortization expense and increased equity in earnings from non-consolidated entities.
Theatrical Exhibition - International Markets
Revenues. Total revenues decreased 5.1%, or $36.6 million, during the six months ended June 30, 2019 compared to the six months ended June 30, 2018. Admissions revenues decreased 8.8%, or $41.5 million, during the six months ended June 30, 2019 compared to the six months ended June 30, 2018, primarily due to an overall decrease in attendance of 1.3% and decline in average ticket price of 7.5%. The decrease in average ticket price was primarily due to decreases in foreign currency translation rates. The decrease in attendance was primarily due to the popularity of films released in the period as compared to the same period a year ago as well as temporary screen closures for theatre refurbishments.
Food and beverage revenues increased 1.1%, or $1.8 million, during the six months ended June 30, 2019 compared to the six months ended June 30, 2018, primarily due to the overall increase of food and beverage per patron of 2.4%, partially offset by the decrease in attendance and decline in foreign currency translation rates.
Total other theatre revenues increased $3.1 million during the six months ended June 30, 2019 compared to the six months ended June 30, 2018, primarily due to increased ticket fees, partially offset by a decline in foreign currency translation rates.
Operating costs and expenses. Operating costs and expenses decreased 3.8%, or $27.1 million, during the six months ended June 30, 2019 compared to the six months ended June 30, 2018. Film exhibition costs decreased $10.0 million during the six months ended June 30, 2019 compared to the six months ended June 30, 2018, primarily due to the decrease in admissions revenues. As a percentage of admissions revenues, film exhibition costs were 41.8% for the six months ended June 30, 2019 and 40.3% for the six months ended June 30, 2018.
Food and beverage costs decreased $0.9 million during the six months ended June 30, 2019 compared to the six months ended June 30, 2018. The decrease in food and beverage costs was primarily due to the decrease in foreign currency translation rates. As a percentage of food and beverage revenues, food and beverage costs were 22.5% for the six months ended June 30, 2019 and 23.3% for the six months ended June 30, 2018.
As a percentage of revenues, operating expense was 34.5% for the six months ended June 30, 2019 and 35.5% during the six months ended June 30, 2018. Rent expense increased $21.0 million during the six months ended June 30, 2019 compared to the six months ended June 30, 2018 primarily due to the adoption of ASC 842 for lease accounting where approximately $19.8 million of prior year principal and interest payments were reclassified as rent expense during
67
the six months ended June 30, 2019 related to build-to-suit financing lease obligations and $6.2 million of non-cash rent expense - purchase accounting was recorded as rent expense, offset by a decline in foreign currency translation rates. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.
General and Administrative Expense:
Merger, acquisition and transaction costs. Merger, acquisition and transaction costs increased $0.2 million during the six months ended June 30, 2019 compared to the six months ended June 30, 2018.
Other. Other general and administrative expense increased $2.6 million, during the six months ended June 30, 2019 compared to the six months ended June 30, 2018.
Depreciation and amortization. Depreciation and amortization decreased $19.8 million during the six months ended June 30, 2019 compared to the six months ended June 30, 2018 primarily due to the adoption of ASC 842 for lease accounting where the financing lease buildings and depreciation were eliminated and a decline in foreign currency translation rates. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.
Interest expense. Interest expense decreased $8.8 million for the six months ended June 30, 2019 compared to the six months ended June 30, 2018, primarily due to the adoption of ASC 842 for lease accounting which reclassified build-to-suit finance lease obligation interest expense to rent and a decline in foreign currency translation rates. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.
Investment income. Investment income increased $12.9 million due to the gain on the sale of our Austria theatres.
Income tax provision (benefit). The income tax provision was $1.8 million for the six months ended June 30, 2019 and the income tax benefit was $0.4 million for the six months ended June 30, 2018. See Note 8—Income Taxes of the Notes to the Condensed Consolidated Financial Statements in Item 1 of Part I of this Form 10-Q for further information.
Net earnings. Net earnings increased $11.9 million during the six months ended June 30, 2019 as a result of lower depreciation and amortization, reduced operating expenses and lower interest expense, offset by lower attendance and the related decrease in revenues, a decline in foreign currency translation rates, higher rent expense and higher income tax provisions.
LIQUIDITY AND CAPITAL RESOURCES
Our consolidated revenues are primarily collected in cash, principally through box office admissions and food and beverage sales. We have an operating “float” which partially finances our operations, and which generally permits us to maintain a smaller amount of working capital capacity. This float exists because admissions revenues are received in cash, while exhibition costs (primarily film rentals) are ordinarily paid to distributors from 20 to 45 days following receipt of box office admissions revenues. Film distributors generally release the films which they anticipate will be the most successful during the summer and year-end holiday seasons. Consequently, we typically generate higher revenues during such periods.
We had working capital deficits (excluding restricted cash) as of June 30, 2019 and December 31, 2018 of $(1,134.6 million) and $(557.5 million), respectively. Working capital included $570.8 million and $0 of operating lease liabilities as of June 30, 2019 and December 31, 2018, respectively. Working capital included $369.8 million and $414.8 million of deferred revenues as of June 30, 2019 and December 31, 2018, respectively. We have the ability to borrow under our Revolving Credit Facility to meet obligations as they come due (subject to limitations on the incurrence of indebtedness in our various debt instruments). As of June 30, 2019, we had $211.6 million available for borrowing, net of letters of credit, under our Revolving Credit Facility. We also maintain a £100.0 million ($127.0 million based on the foreign currency translation rate of 1.2699 on June 30, 2019) revolving credit facility at our Odeon subsidiary. As of June 30, 2019, we had $0 drawn down on the revolving credit facility and had issued £17.0 million ($21.6 million) standby letters of credit in the ordinary course of business, leaving £83.0 million ($105.4 million) available for borrowing.
68
We believe that cash generated from operations, existing cash and cash equivalents, availability under our Revolving Credit Facility and Odeon’s revolving credit facility will be sufficient to fund operations, planned capital expenditures and dividends currently and for at least the next 12 months and enable us to maintain compliance with all financial debt covenants.
As of June 30, 2019, we were in compliance with all financial debt covenants.
Cash Flows from Operating Activities
Cash flows provided by operating activities, as reflected in the condensed consolidated statements of cash flows, were $153.6 million and $297.1 million during the six months ended June 30, 2019 and June 30, 2018, respectively. The decrease in cash flows provided by operating activities was primarily due to decreased attendance levels which drove lower operating results and the adoption of ASC 842 which reclassified approximately $28.0 million of principal payments under build-to-suit finance lease obligations from net cash used in financing activities to net cash used in operating activities during calendar 2019.
Cash Flows from Investing Activities
Cash flows used in investing activities, as reflected in the condensed consolidated statements of cash flows, were $221.3 million and $181.5 million during the six months ended June 30, 2019 and June 30, 2018, respectively. Cash outflows from investing activities include capital expenditures of $229.9 million and $241.1 million during the six months ended June 30, 2019 and June 30, 2018, respectively. Our capital expenditures primarily consisted of strategic growth initiatives and remodels, capital improvements to existing locations in our theatre circuit, and technology upgrades. During the six months ended June 30, 2019, cash flows used in investing activities included the cash outflows of $11.8 million for the acquisition of assets related to 4 theatres in the U.S. markets, offset by the disposition of long-term assets of $21.3 million. During the six months ended June 30, 2018, net cash used in investing activities included proceeds from sale leaseback transactions of $50.1 million and proceeds from the disposition of long-term assets of $13.5 million, offset by the investment in Dreamscape Immersive, Inc. and Central Service Studios, Inc. of $10.0 million. We expect that our cash outflows for capital expenditures, net of landlord contributions, will be approximately $415.0 million for calendar 2019.
We fund the costs of constructing, maintaining and remodeling our theatres through existing cash balances, cash generated from operations, landlord contributions, or borrowed funds, as necessary. We generally lease our theatres pursuant to long-term non-cancelable operating leases which may require the developer, who owns the property, to reimburse us for the construction costs. We may decide to own the real estate assets of new or acquired theatres and, following construction or acquisition, sell and leaseback the real estate assets pursuant to long-term non-cancelable operating leases. See Commitments and Contingencies below for additional discussion of the potential cash outflows.
Cash Flows from Financing Activities
Cash flows used in financing activities, as reflected in the condensed consolidated statements of cash flows, were $54.5 million and $117.9 million during the six months ended June 30, 2019 and June 30, 2018, respectively.
During the six months ended June 30, 2019, cash inflows from financing activities included the proceeds from the issuance of $1,990.0 million of Term Loans due 2026, offset by cash outflows for the repayment of the Term Loan due 2022 of $849.8 million, repayment of the Term Loan due 2023 of $488.7 million, repayments of the 6.0% Senior Secured Notes due 2023 of $230.0 million and payment of the 5.875% Senior Subordinated Notes due 2022 of $375.0 million. Call premiums paid related to the repayment of the 6.0% Senior Secured Notes due 2023 and the 5.875% Senior Subordinated Notes due 2022 were $15.9 million and debt financing costs paid were $11.2 million. See Note 6 – Corporate Borrowings for additional information.
Principal payments under finance lease obligations declined to $6.1 million due primarily to the adoption of ASC 842 where principal payments of $28.0 million for build-to-suit finance lease obligations were reclassified as operating leases and the cash flows were also classified as operating activities. See Note 2 – Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1. for the impact of ASC 842.
On February 15, 2019, our Board of Directors declared a cash dividend in the amount of $0.20 per share of
69
Class A and Class B common stock, paid on March 25, 2019 to stockholders of record on March 11, 2019. On May 3, 2019, our Board of Directors declared a cash dividend in the amount of $0.20 per share of Class A and Class B common stock, paid on June 24, 2019 to stockholders of record on June 10, 2019. We paid dividends and dividend equivalents of $42.6 million and $51.4 million during the six months ended June 30, 2019 and June 30, 2018, respectively.
On August 2, 2019, we declared a cash dividend in the amount of $0.20 per share on our Class A and Class B common stock, payable on September 23, 2019 to stockholders of record on September 9, 2019.
We made tax payments for restricted stock units withholdings of $1.3 million and $1.7 million during the six months ended June 30, 2019 and June 30, 2018, respectively.
During the six months ended June 30, 2018, we paid a total of $19.8 million for treasury stock, including $13.5 million for treasury stock purchased at the end of 2017 and paid for at the beginning of 2018, and $6.3 million for treasury stock purchased and paid for during the six months ended June 30, 2018.
Contractual Obligations, Commitments and Contingencies
We have commitments and contingencies for financing leases, corporate borrowings, operating leases, capital related betterments and pension funding that were summarized in a table in our Annual Report on Form 10–K for the year ended December 31, 2018. Since December 31, 2018, there have been no material changes to the commitments and contingencies outside of the ordinary course of business, except entering into the amended and restated Senior Secured Credit Agreement.
70
Item 3. Quantitative and Qualitative Disclosures about Market Risk
In the ordinary course of business, our financial results are exposed to fluctuations in interest rates and foreign currency exchange rates. In accordance with applicable guidance, we presented a sensitivity analysis showing the potential impact to net income of changes in interest rates and foreign currency exchange rates. For the six months ended June 30, 2019, our analysis utilized a hypothetical 100 basis-point increase or decrease to the average interest rate on our variable rate debt instruments to illustrate the potential impact to interest expense of changes in interest rates. For the six months ended June 30, 2019, our analysis utilized a hypothetical 100 basis-point increase or decrease to market interest rates on our fixed rate debt instruments to illustrate the potential impact to fair value of changes in interest rates.
Similarly, for the same period, our analysis used a uniform and hypothetical 10% strengthening of the U.S. dollar versus the average exchange rates of applicable currencies to depict the potential impact to net income of changes in foreign exchange rates. These market risk instruments and the potential impacts to the condensed consolidated statements of operations for the current year, have not materially fluctuated, individually or in the aggregate from the preceding year; thus, only current year information is presented below.
Market risk on variable-rate financial instruments. At June 30, 2019, we maintained a Senior Secured Credit Facility comprised of a $225.0 million revolving credit facility and $2,000.0 million of Term Loan due 2026. The Senior Secured Credit Facility provides for borrowings at a rate per annum equal to, at our option, either (i) an applicable margin plus a base rate determined by reference to the highest of (a) 0.50% per annum plus the Federal Funds Effective Rate, or (b) the prime rate of Citi or (ii) the LIBOR + 3.0%. The rate in effect at June 30, 2019 for the outstanding Term Loan due 2026 was 5.23% per annum. Increases in market interest rates would cause interest expense to increase and earnings before income taxes to decrease. The change in interest expense and earnings before income taxes would be dependent upon the weighted average outstanding borrowings during the reporting period following an increase in market interest rates. At June 30, 2019, we had no variable-rate borrowings outstanding under our revolving credit facility and had an aggregate principal balance of $1,995.0 million outstanding under the Term Loan due 2026. A 100-basis point change in market interest rates would have increased or decreased interest expense on the Senior Secured Credit Facility by $9.8 million during the six months ended June 30, 2019.
Market risk on fixed-rate financial instruments. Included in long-term corporate borrowings at June 30 2019 were principal amounts of $600.0 million of our Convertible Notes due 2024, $600.0 million of our Notes due 2025, $595.0 million of our Notes due 2026, $475.0 million of our Notes due 2027, and £500.0 million ($635.0 million) of our Sterling Notes due 2024. A 100-basis point change in market interest rates would have caused an increase or (decrease) in the fair value of our fixed rate financial instruments of approximately $138.6 million and ($130.2) million, respectively.
Foreign currency exchange rate risk. We are also exposed to market risk arising from changes in foreign currency exchange rates as a result of our ownership of Odeon and Nordic. Odeon’s revenues and operating expenses are transacted in British Pounds and Euros, and Nordic’s revenues and operating expenses are transacted primarily in Swedish Krona and Euros. U.S. GAAP requires that our subsidiaries use the currency of the primary economic environment in which they operate as their functional currency. If Odeon and Nordic operate in a highly inflationary economy, U.S. GAAP requires that the U.S. dollar be used as the functional currency for Odeon and Nordic. Currency fluctuations in the countries in which we operate result in us reporting exchange gains (losses) or foreign currency translation adjustments. Based upon our ownership in Odeon and Nordic as of June 30, 2019, holding everything else constant, a hypothetical 10% strengthening of the U.S. dollar versus the average exchange rates of applicable currencies to depict the potential impact to net income of changes in foreign exchange rates, would increase the aggregate net earnings of our International markets reportable segment for the six months ended June 30, 2019 by approximately $0.4 million.
Our foreign currency translation rates decreased by approximately 7.0% for the six months ended June 30, 2019 compared to the six months ended June 30, 2018, which did not significantly impact our consolidated net loss for the six months ended June 30, 2019.
71
Item 4. Controls and Procedures.
(a) |
Evaluation of disclosure controls and procedures. |
The Company maintains a set of disclosure controls and procedures designed to ensure that material information required to be disclosed in its filings under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that material information is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. The Company’s Chief Executive Officer and Chief Financial Officer have evaluated these disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10–Q and have determined that such disclosure controls and procedures were effective.
(b) |
Changes in internal control. |
As part of the adoption of ASC Topic 842, the Company implemented new internal controls to ensure we adequately evaluated our contracts and properly assessed the new lease accounting standard’s impact on our consolidated financial statements. There were no other significant changes in the Company’s internal control over financial reporting due to the adoption of the new standard, and no other changes in its internal control over financial reporting as defined in Exchange Act Rule 13a-15(f) during the quarter ended June 30, 2019, that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
72
PART II—OTHER INFORMATION
Item 1. Legal Proceedings
Reference is made to Note 12—Commitments and Contingencies of the Notes to the Company’s Condensed Consolidated Financial Statements contained in Part I of this quarterly report on Form 10–Q for information on certain litigation to which we are a party.
Item 1A. Risk Factors
Reference is made to Part I Item 1A. Risk Factors in our Annual Report on Form 10–K for the year ended December 31, 2018, which sets forth information relating to important risks and uncertainties that could materially adversely affect our business, financial condition or operating results. There have been no material changes to the risk factors contained in our Annual Report on Form 10-K for the year ended December 31, 2018.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
| (a) | None. |
| (b) | None. |
| (c) | Issuer Purchases of Equity Securities |
Purchases of Equity Securities |
||||||||||
Approximate Dollar |
||||||||||
Total Number of |
Value of Shares that |
|||||||||
Shares Purchased as |
May Yet Be |
|||||||||
Part of Publicly |
Purchased Under the |
|||||||||
Total Number of |
Average Price Paid |
Announced Plans or |
Plans or Program (a) |
|||||||
Period |
|
Shares Purchased |
|
Per Share |
|
Programs (a) |
|
(in millions) |
||
April 1, 2019 through April 30, 2019 |
— |
$ |
— |
— |
$ |
44.3 |
||||
May 1, 2019 through May 31, 2019 |
— |
$ |
— |
— |
$ |
44.3 |
||||
June 1, 2019 through June 30, 2019 |
— |
$ |
— |
— |
$ |
44.3 |
||||
Total |
— |
— |
||||||||
| (a) | As announced on August 3, 2017, our Board of Directors authorized a share repurchase program for an aggregate purchase of up to $100.0 million of our common stock, excluding transaction costs. As of June 30, 2019, $44.3 million remained available for repurchase under this plan. A two-year time limit has been set for the completion of this program, which expired August 2, 2019. |
Item 3. Defaults Upon Senior Securities
None.
Item 5. Other Information
None.
73
Item 6. Exhibits.
EXHIBIT INDEX
EXHIBIT |
DESCRIPTION |
|
10.1 |
||
*31.1 |
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Acts of 2002. |
|
*31.2 |
Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Acts of 2002. |
|
*32.1 |
||
**101.INS |
XBRL Instance Document |
|
**101.SCH |
XBRL Taxonomy Extension Schema Document |
|
**101.CAL |
XBRL Taxonomy Extension Calculation Linkbase Document |
|
**101.DEF |
XBRL Taxonomy Extension Definition Linkbase Document |
|
**101.LAB |
XBRL Taxonomy Extension Label Linkbase Document |
|
**101.PRE |
XBRL Taxonomy Extension Presentation Linkbase Document |
* Filed herewith
** Submitted electronically with this Report.
74
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
AMC ENTERTAINMENT HOLDINGS, INC. |
|
Date: August 8, 2019 |
/s/ ADAM M. ARON |
Adam M. Aron |
|
Chief Executive Officer, Director and President |
|
Date: August 8, 2019 |
/s/ CRAIG R. RAMSEY |
Craig R. Ramsey |
|
Executive Vice President and Chief Financial Officer |
75